Non-small cell lung cancer

C3_LUNG_NONSMALL

non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C34.[123457] Cause of death: ICD-10 — C34.[123457] Cancer registry: Topography ICD-O-3 — C34 Cancer registry: Morphology ICD-O-3 — 8046\|8070\|8140 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	6680
4. Check minimum number of events None	6680
5. Include endpoints None	6680
6. Filter based on genotype QC (FinnGen only)	6680

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	C3_LUNG_NONSMALL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C34.[123457]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C34.[123457]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C34
CANC_TOPO_EXCL
CANC_MORPH	8046\|8070\|8140
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Non-small cell lung cancer based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6680	2060	4620
Unadjusted period prevalence (%)	1.63	0.70	2.04
Median age at first event (years)	71.02	68.99	71.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6047: Matched controls
60469

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

710.6

323.0

910

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.1

323.0

1004

1651

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

323.0

322

N02AA05

ATC

oxycodone; systemic

4.1

323.0

1924

6195

H02AB02

ATC

dexamethasone; systemic

8.4

323.0

1821

2956

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

52.6

323.0

809

177

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

24.1

323.0

517

234

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

323.0

515

GDC00

NOMESCO Finland

Lobectomy of lung

221.4

323.0

599

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

323.0

429

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.0

323.0

1886

6098

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

79.4

323.0

941

140

A03FA01

ATC

metoclopramide; systemic, rectal

4.9

323.0

2386

7153

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

323.0

966

WF049

NOMESCO Finland

Radiotherapy of metastasis

11.4

323.0

859

866

L01CA04

ATC

vinorelbine; systemic

105.8

323.0

566

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

45.8

323.0

2078

683

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

52.1

323.0

436

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

62.4

323.0

1187

236

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

19.0

323.0

3350

3716

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

16384.0

323.0

1528

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

323.0

761

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

323.0

467

WF004

NOMESCO Finland

Palliative radiotherapy

13.8

323.0

592

471

UGC12

NOMESCO Finland

Flexible bronchoscopy

15.4

323.0

2565

2762

130

Kela drug reimbursment

Malignant tumour

17.7

323.0

2857

2917

A04AA01

ATC

ondansetron; systemic, rectal

7.1

323.0

979

1602

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

17.3

323.0

760

498

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

323.0

938

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

323.0

832

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

323.0

349

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

11574.5

323.0

984

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

35.4

323.0

459

140

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

48.3

323.0

713

167

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

323.0

710

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

20.5

319.9

490

259

Z51.5

ICD-10 Finland

Palliative care

5.5

318.7

1051

2235

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

307.9

293

GD1AD

NOMESCO Finland

Thorax CT examination

7.4

302.8

777

1185

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

25.8

296.7

422

175

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

47.9

294.0

361

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

47.3

273.0

336

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.3

268.6

694

1061

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

39.2

266.6

341

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

20.2

257.3

395

208

R84

ICPC

Malignant neoplasm bronchus/lung

67.6

245.2

284

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

22.1

234.3

349

167

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

226.5

216

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

+∞

225.4

215

JN4BD

NOMESCO Finland

Extensive body CT

3.4

219.9

1223

4142

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

8.4

202.4

470

602

TGD00

NOMESCO Finland

Needle biopsy of lung

47.0

198.2

244

WZC30

NOMESCO Finland

Teaching

3.2

194.0

1182

4247

R03BB04

ATC

tiotropium bromide; inhalant

3.0

193.4

1294

4961

WF002

NOMESCO Finland

Radical radiotherapy

4.7

192.2

718

1693

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

33.8

189.2

250

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

188.5

180

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

186.4

2434

13616

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

179.1

3142

20036

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

4.6

179.1

684

1644

XX3DW

NOMESCO Finland

Time consuming IT work

3.4

174.4

974

3258

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

5.9

165.9

494

895

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

107.2

162.0

177

A04AA55

ATC

palonosetron, combinations; systemic

9.2

159.4

348

399

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

155.8

939

3299

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

27.8

155.0

215

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

7.7

154.9

379

523

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

+∞

153.8

147

191

Kela drug reimbursment

Erlotinib

101.6

152.9

168

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

8.1

151.7

359

470

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

18.1

147.8

235

135

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.0

146.5

502

1068

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.0

144.1

626

1686

C34.21

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma

+∞

142.2

136

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

142.2

136

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.4

140.7

553

1354

H02AB06

ATC

prednisolone; systemic

2.0

140.7

3081

20707

A04AA02

ATC

granisetron; systemic, transdermal

4.1

140.4

589

1535

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

30.8

139.3

188

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

38.8

138.4

177

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

28.2

136.9

189

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

129.5

1957

11217

JN4AD

NOMESCO Finland

Body CT examination

3.2

129.0

759

2597

L01XE03

ATC

[U] erlotinib; oral

107.8

125.5

137

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

31.4

125.2

168

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.7

125.1

588

1688

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

9.8

124.9

262

279

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.5

123.7

391

756

R04.2

ICD-10 Finland

Haemoptysis

4.3

119.5

476

1175

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

119.3

1328

6588

C34.02

ICD-10 Finland

Malignant tumor of the main bronchial adenocarcinoma

+∞

118.1

113

C34.35

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma

+∞

112.8

108

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.8

110.2

510

1439

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

8.9

109.8

243

284

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

95.0

109.4

121

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.6

107.9

402

927

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

7.6

107.7

264

363

J01MA14

ATC

moxifloxacin; systemic

2.8

107.2

777

3033

A98

ICPC

Health maint/preventive medicine

0.5

106.6

3536

43737

GDD00

NOMESCO Finland

Pneumonectomy

217.7

103.9

107

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.1

102.9

342

698

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

37.4

102.7

132

N02AX02

ATC

tramadol; systemic, rectal

1.8

101.0

2716

18788

J93.8

ICD-10 Finland

Other pneumothorax

18.9

98.2

153

C34

ICD-10 Finland

Malignant neoplasm of bronchus and lung

67.0

96.9

112

C34.89

ICD-10 Finland

Malignant overall tumor of the bronchus and lung other or unspecified histology

30.6

93.5

126

R03AC02

ATC

salbutamol; inhalant

1.7

90.7

2813

20108

ZX120

NOMESCO Finland

Intravenous

2.6

90.7

752

3155

C34.17

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary carcinoid

+∞

89.8

5826

FHL

Lobectomy or bilobectomy

41.1

89.8

113

XG410

NOMESCO Finland

Flow-volume spirometry

3.7

89.3

416

1175

J01MA12

ATC

levofloxacin; systemic

2.0

89.1

1436

8203

1623A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]

47.7

88.4

108

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

87.9

617

2344

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.2

87.1

286

575

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

5.1

86.8

289

590

L01XE13

ATC

[U] afatinib; oral

+∞

86.6

N07BA03

ATC

varenicline; oral

4.7

86.5

314

703

1BA04

NOMESCO Finland

106.1

86.1

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.7

85.5

258

470

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

22.6

84.6

124

C34.37

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung carcinoid

+∞

84.6

B01AB05

ATC

enoxaparin; parenteral

1.8

84.1

1930

12457

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

18.4

82.9

130

C34.20

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung without histology

47.9

81.1

WX250

NOMESCO Finland

Intercostal blockade

32.3

79.2

105

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.4

78.7

750

3375

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

37.6

78.1

100

ZX050

NOMESCO Finland

Stereotactic radiotherapy

10.6

78.0

155

149

N02AA01

ATC

morphine; systemic, rectal

5.5

75.9

235

441

ZX090

NOMESCO Finland

Other technic of radiotherapy

4.3

75.1

295

714

GDC10

NOMESCO Finland

Bilobectomy of lung

133.4

74.1

3004

Kela drug reimbursment

Osimertinib

+∞

73.0

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

21.8

72.3

107

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

13.5

71.7

127

A06AH03

ATC

naloxegol; oral

7.4

71.1

175

242

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

21.3

70.5

105

R4110

NOMESCO Finland

Physiotherapy

1.8

70.4

1591

10095

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

11.5

69.3

132

117

GEA00

NOMESCO Finland

Mediastinoscopy

19.9

68.4

104

TGA30

NOMESCO Finland

Thoracocentesis

7.5

67.9

165

224

8140/3-C34.2

ICD-O-3

Adenocarcinoma, NOS, of middle lobe, lung

+∞

67.8

341

Kela drug reimbursment

Afatinib and gefitinib

+∞

67.8

C34.85

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma

+∞

66.8

C34.09

ICD-10 Finland

Malignant tumor of the main bronchus other or unspecified histology

40.1

65.8

1519

Kela drug reimbursment

+∞

65.7

N03AX16

ATC

pregabalin; oral

1.8

65.1

1349

8286

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.1

64.0

212

430

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

64.0

565

2430

C34.13

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma

+∞

62.6

A04AD12

ATC

aprepitant; systemic

6.0

62.6

180

309

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.1

62.2

134

150

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

5.0

61.6

205

418

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

61.0

1528

9925

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

60.9

1320

8200

N06DX01

ATC

memantine; oral

0.2

60.8

3177

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

60.5

843

4469

C34.14

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma

+∞

59.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

19.2

59.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

58.5

979

5562

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.7

58.5

274

775

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

32.5

58.3

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

28.6

57.9

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

7.5

57.7

140

190

L01EB04

ATC

osimertinib; oral

+∞

57.4

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.4

56.8

288

867

WX892

NOMESCO Finland

Monitored bed care

2.3

56.2

573

2643

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.2

55.9

139

196

J94.8

ICD-10 Finland

Other specified pleural conditions

4.3

55.0

216

522

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.5

54.9

450

1855

D38.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified

16.5

54.3

8551/3-C34.1

ICD-O-3

Acinar cell cystadenocarcinoma of upper lobe, lung

+∞

53.2

C34.33

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma

+∞

53.2

B01AB10

ATC

tinzaparin; parenteral

2.4

53.0

471

2027

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

13.9

53.0

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.2

52.2

208

510

TGC00

NOMESCO Finland

Bronchial lavation

3.7

51.9

241

676

8070/3-C34.0

ICD-O-3

Squamous cell carcinoma, NOS, of main bronchus

+∞

51.1

C34.29

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology

51.3

50.9

WX402

NOMESCO Finland

General anaesthesia

1.9

50.8

801

4431

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

8.2

50.7

116

144

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

50.0

426

1791

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

49.2

443

1914

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

48.1

1227

7926

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

47.6

501

2341

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.2

47.2

2547

R06.0

ICD-10 Finland

Dyspnoea

1.6

46.2

1510

10411

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

11.8

46.0

C34.34

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma

+∞

45.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

6.7

45.7

119

180

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.7

45.5

336

1303

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

45.4

2886

1CD01

NOMESCO Finland

18.6

45.3

L01XE02

ATC

[U] gefitinib; oral

+∞

44.8

8240/3-C34.3

ICD-O-3

Neuroendocrine tumor, NOS, of lower lobe, lung

+∞

44.8

1625A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]

49.5

44.8

C34.95

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma

440.8

44.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

5.0

43.5

143

289

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

10.2

43.4

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

42.7

323

1270

PJD99

NOMESCO Finland

Excision of other lymph nodes

31.4

42.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

42.2

1158

7600

J93.9

ICD-10 Finland

Pneumothorax, unspecified

8.6

42.0

110

C34.97

ICD-10 Finland

Malignant tumor in unspecified location in bronchial and pulmonary carcinoid

+∞

41.7

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.2

41.7

133

260

R03BB01

ATC

ipratropium bromide; inhalant

2.2

41.0

465

2243

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

3.5

40.8

198

577

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

8.8

40.5

101

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.4

40.4

124

232

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

8.6

39.8

104

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.7

39.8

1349

18332

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

5.1

39.8

128

253

GD004

NOMESCO Finland

Palliative radiotherapy of trachea, bronchi and lungs

108.3

39.7

P20

ICPC

Memory disturbance

0.5

39.1

302

5929

1BC05

NOMESCO Finland

137.5

38.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

38.1

2335

18340

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

37.8

899

5648

GAA31

NOMESCO Finland

Thoracoscopy

12.2

37.8

8070/3-C34.2

ICD-O-3

Squamous cell carcinoma, NOS, of middle lobe, lung

+∞

37.5

3001

Kela drug reimbursment

Alectinib

+∞

37.5

L03AA13

ATC

pegfilgrastim; parenteral

3.0

37.5

230

795

N06DA02

ATC

donepezil; oral

0.3

37.5

2657

5828

FHL

Pneumectomy

70.3

36.9

1504

Kela drug reimbursment

Alectinib

+∞

36.5

8046/3-C34.9

ICD-O-3

Non-small cell carcinoma of lung, NOS

+∞

36.5

M05BX04

ATC

denosumab; parenteral

2.4

36.5

319

1358

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.2

36.4

203

657

L01CB01

ATC

etoposide; systemic

9.0

36.3

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

13.2

36.3

R85

ICPC

Malignant neopl respiratory other

21.4

36.1

N06DA03

ATC

rivastigmine; oral, transdermal

0.2

36.0

1704

GDC20

NOMESCO Finland

Lobectomy of lung and sleeve resection of bronchus

186.1

35.8

8480/3-C34.3

ICD-O-3

Mucinous adenocarcinoma of lower lobe, lung

+∞

35.4

J86.9

ICD-10 Finland

Pyothorax without fistula

5.4

35.3

109

206

F03

ICD-10 Finland

Unspecified dementia

0.3

35.2

2292

A79

ICPC

Malignancy NOS

4.2

35.1

137

331

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.8

34.9

119

251

Z72.0

ICD-10 Finland

Tobacco use

3.8

34.9

151

401

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

7.7

34.8

108

B01AB04

ATC

dalteparin; parenteral

2.3

34.4

339

1531

GDC11

NOMESCO Finland

Thoracoscopic bilobectomy of lung

+∞

34.4

SFA10

NOMESCO Finland

Fillning on one surface of tooth

0.7

34.0

1312

17530

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

4.4

33.7

126

292

8240/3-C34.9

ICD-O-3

Neuroendocrine tumor, NOS, of lung, NOS

175.9

33.7

1623C

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]

50.3

33.4

8551/3-C34.3

ICD-O-3

Acinar cell cystadenocarcinoma of lower lobe, lung

+∞

33.4

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.6

33.3

512

8312

SPAT1053

SPAT

Memory test

0.6

33.1

463

7693

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.6

32.8

744

11044

8250/3-C34.9

ICD-O-3

Lepidic adenocarcinoma of lung, NOS

54.6

32.2

GCA05

NOMESCO Finland

Bronchoscopic laser therapy of lesion of bronchus

40.3

32.1

A02BC02

ATC

pantoprazole; systemic

1.4

31.9

3455

29690

J01AA02

ATC

doxycycline; systemic

1.4

31.6

4184

37199

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.2

31.4

1685

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.8

31.3

135

358

L01ED03

ATC

alectinib; oral

+∞

31.3

8046/3-C34.1

ICD-O-3

Non-small cell carcinoma of upper lobe, lung

+∞

31.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

30.8

312

1428

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.8

30.8

135

363

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

30.8

1136

15361

ZX095

NOMESCO Finland

Combined chemoradiotherapy

7.1

30.7

108

L01XE35

ATC

[U] osimertinib; oral

+∞

30.2

C34.27

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung carcinoid

+∞

30.2

C34.05

ICD-10 Finland

Malignant tumor of the main bronchial other non-microcellular carcinoma

+∞

30.2

169

Kela drug reimbursment

Crizotinib

+∞

30.2

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

30.2

1668

21082

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.6

30.1

772

11201

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

22.8

30.0

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.7

29.9

1027

14086

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

29.3

639

3894

L01EB03

ATC

afatinib; oral

+∞

29.2

GCA32

NOMESCO Finland

Endoscopic insertion of stent into bronch

40.3

28.9

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

28.9

2017

24641

8240/3-C34.1

ICD-O-3

Neuroendocrine tumor, NOS, of upper lobe, lung

293.3

28.8

GD002

NOMESCO Finland

Radical radiotherapy of trachea, bronchi and lungs

80.5

28.7

B02AA02

ATC

tranexamic acid; systemic

1.7

28.4

594

3571

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

5.5

28.2

157

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.9

27.7

115

296

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

5.2

27.2

168

WX330

NOMESCO Finland

Paravertebral ansthesia

97.1

26.6

GD2FN

NOMESCO Finland

Lung ventilation distribution isotope examination (radiospirometry)

97.1

26.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

26.1

735

4799

N05CF01

ATC

zopiclone; oral

1.4

26.1

1887

14983

L01XE36

ATC

[U] alectinib; oral

+∞

26.1

ZX080

NOMESCO Finland

Image guided radiotherapy

3.3

26.0

135

417

WX600

NOMESCO Finland

Single shot through catheter

5.1

25.8

166

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.6

25.7

607

8991

GDB10

NOMESCO Finland

Wedge resection of lung

14.4

25.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

7.4

25.5

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

4.3

25.5

226

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

7.5

25.3

1240

FHL

Bronchoscopy

3.2

24.9

135

431

GAC00

NOMESCO Finland

Biopsy of pleura

6.1

24.9

112

C34.84

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary macrocellular anaplastic carcinoma

251.2

24.7

WW200

SPAT

0.4

24.6

2326

XG460

NOMESCO Finland

Short time oxymetry

2.8

24.6

164

600

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.6

24.6

594

8771

J43.9

ICD-10 Finland

Emphysema, unspecified

2.8

24.5

160

578

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

10.8

24.5

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

17.4

24.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

4.8

24.3

169

XKD00

NOMESCO Finland

Uroflowmetry

0.7

24.2

660

9511

H13

ICPC

Plugged feeling ear

0.6

24.0

496

7571

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

12.4

24.0

8250/3-C34.3

ICD-O-3

Lepidic adenocarcinoma of lower lobe, lung

+∞

24.0

WW500

NOMESCO Finland

Blood transfusion

2.1

23.3

261

1250

R95

ICPC

Chron obstructive pulmonary disease

2.3

23.2

213

931

A06AD11

ATC

lactulose; oral

1.5

23.2

1029

7439

L01XE16

ATC

[U] crizotinib; oral

+∞

22.9

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

22.8

2732

31388

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

7.5

22.8

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

22.8

450

6939

325

Kela drug reimbursment

Erlotinib

120.4

22.6

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

0.3

22.5

1557

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.6

22.3

311

5207

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

21.9

137

480

C34.25

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung other non-microcellular carcinoma

+∞

21.9

L57.0

ICD-10 Finland

Actinic keratosis

0.5

21.7

235

4205

GWE00

NOMESCO Finland

Reoperation for deep haemorrhage in thoracic surgery

22.2

21.6

L03AA02

ATC

filgrastim; parenteral

2.6

21.6

158

612

8250/3-C34.1

ICD-O-3

Lepidic adenocarcinoma of upper lobe, lung

220.7

21.6

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

9.8

21.5

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.3

21.4

1299

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

16.3

21.4

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

21.3

276

1406

8140/3-C34.0

ICD-O-3

Adenocarcinoma, NOS, of main bronchus

+∞

20.8

C34.04

ICD-10 Finland

Malignant tumor of the main bronchial macrocellular anaplastic carcinoma

+∞

20.8

C34.83

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma

+∞

20.8

R52.0

ICD-10 Finland

Acute pain

2.7

20.8

146

554

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

0.7

20.7

1006

13153

1622A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]

77.0

20.7

K02.1

ICD-10 Finland

Caries of dentine

0.7

20.5

1482

18283

G20

ICD-10 Finland

Parkinson disease

0.3

20.5

1355

L15

ICPC

Knee symptom/complaint

0.6

20.4

443

6706

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

14.2

20.3

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

20.3

384

5987

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

4.3

20.2

176

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.6

20.1

154

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

5.0

20.1

128

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

20.0

229

1109

SPAT1109

SPAT

Analgesia with portable analgesic pump

4.9

20.0

133

J01FA06

ATC

roxithromycin; oral

1.3

19.9

1953

16090

1628A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]

57.7

19.9

C34.87

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary carcinoid

+∞

19.8

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.7

19.7

786

10623

GDB20

NOMESCO Finland

Segmental resection of lung

73.7

19.7

GDC13

NOMESCO Finland

Extended lobectomy or bilobectomy of lung

200.6

19.6

8010/3-C34.1

ICD-O-3

Carcinoma, NOS, of upper lobe, lung

200.6

19.6

D19

ICPC

Teeth/gum symptom/complaint

0.6

19.5

475

7028

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.4

19.5

170

725

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

13.8

19.5

UGC02

NOMESCO Finland

Rigid bronchoscopy

9.6

19.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

19.3

863

6233

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

13.3

19.2

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.5

19.1

153

GDA10

NOMESCO Finland

Biopsy of lung

8.3

19.1

L03AA14

ATC

lipegfilgrastim; parenteral

3.2

19.1

102

325

RS221

NOMESCO Finland

3.5

18.9

257

SPAT1325

SPAT

Vaccination

0.7

18.9

1268

15851

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

18.9

875

6358

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

0.3

18.8

1194

L01EB01

ATC

gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)

+∞

18.8

C34.93

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary bronchoalveolar carcinoma

+∞

18.8

R03DA04

ATC

theophylline; systemic, rectal

1.6

18.5

480

3060

EB1AA

NOMESCO Finland

Tooth X-ray examination

0.8

18.3

1539

18684

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

18.3

744

5260

SPAT1310

SPAT

Counselling related to known health issue

0.7

18.3

917

11964

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.6

18.2

224

3880

JN6AD

NOMESCO Finland

CT of torso and neck

3.4

18.2

260

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

17.6

18.2

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.2

18.1

186

860

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.6

18.0

318

5043

D82

ICPC

Teeth/gum disease

0.7

17.9

693

9433

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

17.8

1460

17798

C39.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the respiratory system

26.8

17.8

8046/3-C34.3

ICD-O-3

Non-small cell carcinoma of lower lobe, lung

+∞

17.7

C34.23

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma

+∞

17.7

KMAK

NOMESCO Finland

0.8

17.6

1342

16517

2391A

ICD-9 Finland

Neoplasm of unspecified nature, Respiratory system

5.0

17.4

110

Z01.2

ICD-10 Finland

Dental examination

0.7

17.4

944

12186

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

18.6

17.3

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

17.2

141

2735

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.8

16.9

1273

15710

SDA01

NOMESCO Finland

Simple parodonthologic therapy

0.7

16.8

456

6611

SPAT1301

SPAT

No procedures

0.7

16.7

1047

13250

SPAT1043

SPAT

Audiometry

0.6

16.6

247

4082

R50.9

ICD-10 Finland

Fever, unspecified

1.5

16.6

695

4937

Z51.0

ICD-10 Finland

Radiotherapy session

3.0

16.6

316

8000/3-C34.3

ICD-O-3

Neoplasm, malignant of lower lobe, lung

9.8

16.6

G30.8

ICD-10 Finland

Other Alzheimer disease

0.2

16.6

887

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.6

16.5

335

5158

C34.96

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma

11.6

16.5

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

10.4

16.1

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

16.0

483

6874

G04BD12

ATC

mirabegron; oral

0.6

16.0

231

3842

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

0.5

15.8

170

3053

N05AX08

ATC

risperidone; systemic

0.5

15.8

167

3014

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

3.1

15.7

281

C34.94

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary macrocellular anaplastic carcinoma

+∞

15.6

C34.03

ICD-10 Finland

Malignant tumor of the main bronchial bronchoalveolar carcinoma

+∞

15.6

8140/2-C34.1

ICD-O-3

Adenocarcinoma in situ, NOS, of upper lobe, lung

+∞

15.6

SDA02

NOMESCO Finland

Parodonthologic therapy

0.7

15.6

745

9828

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

4.0

15.6

157

C34.07

ICD-10 Finland

Malignant tumor of the main bronchus carcinoid

160.4

15.5

B01AF01

ATC

rivaroxaban; oral

0.6

15.4

293

4577

1623X

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]

8.9

15.4

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

15.3

423

6126

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.4

15.3

1714

H02

ICPC

Hearing complaint

0.6

15.3

325

4953

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

0.6

15.2

268

4255

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

15.1

913

11642

G04CA01

ATC

alfuzosin; oral

0.7

15.0

464

6582

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

0.7

15.0

580

7913

SPAT1312

SPAT

General health counselling

0.7

15.0

873

11190

DAX08

NOMESCO Finland

Fitting of hearing aid

0.4

15.0

1628

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

6.3

15.0

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

6.1

14.9

P70

ICPC

Dementia

0.2

14.9

794

C09CA01

ATC

losartan; oral

0.7

14.8

784

10187

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

0.6

14.7

203

3416

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.7

14.6

105

VALMI

NOMESCO Finland

0.7

14.6

450

6388

C10AA05

ATC

atorvastatin; oral

0.8

14.6

1576

18692

363

Kela drug reimbursment

Crizotinib

+∞

14.6

8240/3-C34.2

ICD-O-3

Neuroendocrine tumor, NOS, of middle lobe, lung

+∞

14.6

XX9XW

NOMESCO Finland

5.0

14.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

14.5

867

6570

A04AA03

ATC

tropisetron; systemic

6.3

14.5

5188X

ICD-9 Finland

Other diseases of lung

5.1

14.5

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

0.8

14.5

1384

16653

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.8

14.5

1467

17529

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

14.4

449

6358

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

14.2

158

2813

205

Kela drug reimbursment

Chronic hypertension

0.8

14.2

1373

16502

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

3.1

14.2

245

R24

ICPC

Haemoptysis

4.3

14.2

118

C10AA07

ATC

rosuvastatin; oral

0.7

14.2

723

9454

G04CA02

ATC

tamsulosin; oral

0.8

14.1

1363

16391

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

0.7

14.1

495

6871

G04CB02

ATC

dutasteride; oral

0.6

14.1

227

3681

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

7.0

14.1

N06DA04

ATC

galantamine; oral

0.3

14.0

839

WF099

NOMESCO Finland

Other radiotherapy

4.6

14.0

106

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

13.9

373

5431

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.0

13.9

260

A07AA02

ATC

nystatin; oral

1.7

13.9

317

1951

G47.3

ICD-10 Finland

Sleep apnoea

0.7

13.7

528

7216

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

13.6

1412

16857

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

0.7

13.6

585

7856

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

13.6

1716

GEB40

NOMESCO Finland

Mediastinotomy and extended excision of lesion

75.3

13.6

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

13.6

447

3018

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

0.7

13.6

508

6976

8480/3-C34.1

ICD-O-3

Mucinous adenocarcinoma of upper lobe, lung

+∞

13.5

8013/3-C34.9

ICD-O-3

Large cell neuroendocrine carcinoma of lung, NOS

+∞

13.5

8249/3-C34.3

ICD-O-3

Neuroendocrine tumor, grade 2 of lower lobe, lung

+∞

13.5

8480/3-C34.9

ICD-O-3

Mucinous adenocarcinoma of lung, NOS

140.3

13.4

F01.9

ICD-10 Finland

Vascular dementia, unspecified

0.2

13.3

672

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

13.3

1167

9367

Z00.0

ICD-10 Finland

General medical examination

0.7

13.3

481

6644

N04BD01

ATC

selegiline; oral

0.1

13.3

524

N05BA04

ATC

oxazepam; oral

1.3

13.3

1147

9189

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

13.2

1256

15160

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

4.2

13.2

117

P17

ICPC

Tobacco abuse

3.6

13.1

167

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

13.1

801

6087

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

13.1

243

1411

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.6

13.0

183

3066

SPAT1153

SPAT

Removal of sutures

0.8

12.9

1066

13088

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

12.9

332

2113

GCA02

NOMESCO Finland

Bronchoscopic electrocoagulation of lesion of bronchus

19.0

12.9

M01AX05

ATC

glucosamine; oral

0.7

12.8

643

8441

A02BA02

ATC

ranitidine; systemic

1.3

12.8

1113

8920

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

2.0

12.7

167

861

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

12.7

1182

14306

TXQ05

NOMESCO Finland

Puncture of skin, site unspecified

70.0

12.6

8012/3-C34.1

ICD-O-3

Large cell carcinoma, NOS, of upper lobe, lung

+∞

12.5

8140/3-C34.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of lung

+∞

12.5

8550/3-C34.1

ICD-O-3

Acinar cell carcinoma of upper lobe, lung

+∞

12.5

ZYC01

SPAT

0.4

12.5

1039

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.8

12.4

1081

13191

A02BC01

ATC

omeprazole; systemic

1.3

12.4

1474

12295

Z57.2

ICD-10 Finland

Occupational exposure to dust

4.9

12.3

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

7.1

12.2

L17

ICPC

Foot/toe symptom/complaint

0.7

12.2

700

9021

JN4DD

NOMESCO Finland

Scout CT scan of torso

9.6

12.2

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.8

12.2

272

D01BA02

ATC

terbinafine; oral; topical

0.8

12.0

779

9873

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

8.2

12.0

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

12.0

155

794

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

12.0

891

11096

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

3.2

11.9

197

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

2.8

11.9

263

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

11.9

181

985

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

6.0

11.9

R4190

NOMESCO Finland

Nutritional therapy

2.2

11.9

119

547

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

7.5

11.9

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.7

11.8

288

7866A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest

7.9

11.8

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.5

11.8

110

2055

D14.3

ICD-10 Finland

Benign neoplasm: Bronchus and lung

6.1

11.8

L13

ICPC

Hip symptom/complaint

0.7

11.8

383

5391

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

11.7

111

499

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

11.7

210

3321

L90

ICPC

Osteoarthrosis of knee

0.5

11.6

1883

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

6.9

11.6

S27.0

ICD-10 Finland

Traumatic pneumothorax

3.3

11.5

175

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.1

11.5

133

651

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.9

11.5

119

8230/3-C34.1

ICD-O-3

Solid carcinoma, NOS, of upper lobe, lung

+∞

11.5

8249/3-C34.1

ICD-O-3

Neuroendocrine tumor, grade 2 of upper lobe, lung

+∞

11.5

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

5.4

11.4

1625C

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]

120.2

11.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.8

11.4

125

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

0.7

11.4

386

5392

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

11.3

366

2461

A06AC01

ATC

ispaghula (psylla seeds); oral

0.8

11.3

765

9652

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

0.5

11.3

1774

Z97.4

ICD-10 Finland

Presence of external hearing-aid

0.5

11.3

116

2105

GA2CT

NOMESCO Finland

Pleural biopsy with CT guidance

35.1

11.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.0

11.2

107

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

6.5

11.2

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

0.5

11.2

1700

K78

ICPC

Atrial fibrillation/flutter

0.6

11.2

238

3634

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.7

11.2

227

1355

J01DA01

ATC

[U] cefalexin; systemic

1.2

11.1

3120

28397

N03AX14

ATC

levetiracetam; systemic

2.1

11.1

119

567

L03

ICPC

Low back symptom/complaint

0.7

11.1

562

7375

UGB02

NOMESCO Finland

Tracheoscopy

6.4

11.0

207

Kela drug reimbursment

Chronic arrhythmias

0.7

11.0

575

7517

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.7

11.0

370

5179

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

10.9

108

496

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.0

10.9

199

R03AC13

ATC

formoterol; inhalant

1.6

10.9

260

1625

I50.0

ICD-10 Finland

Congestive heart failure

0.7

10.9

286

4187

KED22

NOMESCO Finland

Transurethral resection of prostate

0.7

10.9

253

3787

M16.1

ICD-10 Finland

Other primary coxarthrosis

0.7

10.9

335

4760

B01AF02

ATC

apixaban; oral

0.7

10.8

280

4108

R03BA02

ATC

budesonide; inhalant

1.3

10.8

736

5682

H61.2

ICD-10 Finland

Impacted cerumen

0.5

10.8

1830

WE198

NOMESCO Finland

Palliative cystotatic therapy

10.6

10.7

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.2

10.7

530

1629A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]

28.0

10.7

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.6

10.7

219

3366

8010/3-C34.3

ICD-O-3

Carcinoma, NOS, of lower lobe, lung

21.5

10.7

OAB42

SPAT

0.4

10.6

987

S18

ICPC

Laceration/cut

0.8

10.5

1525

17681

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

7.0

10.5

U07

ICPC

Urine symptom/complaint other

0.5

10.4

1769

8013/3-C34.1

ICD-O-3

Large cell neuroendocrine carcinoma of upper lobe, lung

+∞

10.4

8020/3-C34.1

ICD-O-3

Carcinoma, undifferentiated, NOS, of upper lobe, lung

+∞

10.4

8560/3-C34.3

ICD-O-3

Adenosquamous carcinoma of lower lobe, lung

+∞

10.4

8070/3-C34.8

ICD-O-3

Squamous cell carcinoma, NOS, of overlapping lesion of lung

+∞

10.4

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

10.4

318

4525

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.0

10.4

190

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

0.6

10.4

131

2249

R03AC18

ATC

indacaterol; inhalant

2.9

10.3

207

SPAT1097

SPAT

Recording of ECG

0.7

10.2

439

5908

R81

ICPC

Pneumonia

1.8

10.2

166

925

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.6

10.2

186

2930

J96.1

ICD-10 Finland

Chronic respiratory failure

1.8

10.0

161

893

I50.9

ICD-10 Finland

Heart failure, unspecified

0.8

10.0

661

8376

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

0.5

10.0

1774

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.2

10.0

156

C38.4

ICD-10 Finland

Malignant neoplasm: Pleura

9.1

10.0

J98.4

ICD-10 Finland

Other disorders of lung

6.1

9.9

J98.1

ICD-10 Finland

Pulmonary collapse

3.1

9.9

168

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.4

9.9

329

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

4.4

9.9

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

0.6

9.9

160

2589

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

9.9

309

2065

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.6

9.8

123

2118

JN5AP

NOMESCO Finland

Total body PET (1 picture)

12.2

9.8

R05CB01

ATC

acetylcysteine; inhalant, oral

2.0

9.8

129

668

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

9.7

801

9878

C09AA02

ATC

enalapril; systemic

0.8

9.7

862

10541

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

9.7

396

2801

ZXA00

NOMESCO Finland

Right side

1.2

9.7

1397

11861

DFF00

NOMESCO Finland

Pure tone audiometry

0.6

9.7

208

3163

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

0.3

9.7

692

1XC18

NOMESCO Finland

55.1

9.6

1624A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]

55.1

9.6

N05AD01

ATC

haloperidol; systemic

1.7

9.6

199

1197

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

5.3

9.6

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.6

9.6

129

2181

R02

ICPC

Shortness of breath/dyspnoea

1.4

9.5

544

4087

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

3.3

9.5

141

HMAK

NOMESCO Finland

0.6

9.5

189

2919

R03BB07

ATC

umeclidinium bromide; inhalant

3.2

9.4

147

J43.2

ICD-10 Finland

Centrilobular emphysema

4.5

9.4

C10AA01

ATC

simvastatin; oral

0.8

9.4

2214

24626

GDA20

NOMESCO Finland

Excision of lesion of lung

7.5

9.4

8550/3-C34.3

ICD-O-3

Acinar cell carcinoma of lower lobe, lung

+∞

9.4

8020/3-C34.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of lung, NOS

+∞

9.4

8560/3-C34.1

ICD-O-3

Adenosquamous carcinoma of upper lobe, lung

+∞

9.4

M79.6

ICD-10 Finland

Pain in limb

0.8

9.4

1060

12625

UKC02

NOMESCO Finland

Cystoscopy

0.8

9.3

717

8917

H25.1

ICD-10 Finland

Senile nuclear cataract

0.8

9.3

1234

14462

A10BK03

ATC

empagliflozin; oral

0.6

9.2

117

2007

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.4

9.2

128

C10AX09

ATC

ezetimibe; oral

0.7

9.2

268

3843

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.7

9.2

196

1192

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

9.1

952

7781

C08CA13

ATC

lercanidipine; oral

0.7

9.1

386

5203

SPAT1304

SPAT

Counselling and guidance related to ageing

0.6

9.1

195

2966

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.8

9.1

1043

12403

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.7

9.0

255

3682

N87

ICPC

Parkinsonism

0.2

9.0

439

C43.12

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type

36.7

9.0

SFA00

NOMESCO Finland

Small filling

0.7

9.0

225

3321

V03AA01

ATC

2.2

8.9

372

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

18.6

8.9

OAA67

SPAT

0.3

8.9

651

K86

ICPC

Hypertension uncomplicated

0.7

8.9

330

4543

GD6AD

NOMESCO Finland

CT of chest and neck

5.5

8.9

S02.51

ICD-10 Finland

Fracture of tooth, open

0.6

8.8

153

2438

R05FB02

ATC

cough suppressants and expectorants

1.2

8.8

1906

16818

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

8.8

650

8125

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.8

8.7

487

6317

Z96.1

ICD-10 Finland

Presence of intraocular lens

0.8

8.7

488

6327

R05

ICD-10 Finland

Cough

1.3

8.7

793

6371

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.0

8.7

114

589

116

Kela drug reimbursment

Prostate cancer

0.7

8.7

271

3847

XJH00

NOMESCO Finland

Transanal ultrasonography

0.7

8.6

258

3686

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

0.8

8.6

713

8802

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.7

8.6

209

B01AA03

ATC

warfarin; systemic

0.8

8.6

1071

12650

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.7

8.6

217

3201

R03AC12

ATC

salmeterol; inhalant

1.5

8.6

276

1855

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

0.4

8.6

949

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.7

8.4

206

SPAT1263

SPAT

Sampling

0.8

8.4

1476

16888

N07BC02

ATC

methadone; systemic

5.1

8.4

A02BX02

ATC

sucralfate; oral

1.6

8.4

235

1531

R03BB02

ATC

oxitropium bromide; inhalant

2.4

8.4

304

L01EB02

ATC

erlotinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)

90.2

8.4

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

0.6

8.4

164

2543

J01FA09

ATC

clarithromycin; systemic

1.2

8.4

1150

9692

H02AB07

ATC

prednisone; oral

1.3

8.4

718

5721

8013/3-C34.3

ICD-O-3

Large cell neuroendocrine carcinoma of lower lobe, lung

+∞

8.3

8072/3-C34.3

ICD-O-3

Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of lower lobe, lung

+∞

8.3

8071/3-C34.1

ICD-O-3

Squamous cell carcinoma, keratinizing, NOS, of upper lobe, lung

+∞

8.3

C34.24

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung macrocellular anaplastic carcinoma

+∞

8.3

L01ED01

ATC

crizotinib; oral

+∞

8.3

8260/3-C34.1

ICD-O-3

Papillary adenocarcinoma, NOS, of upper lobe, lung

+∞

8.3

R33

ICD-10 Finland

Retention of urine

0.7

8.3

334

4543

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

0.8

8.3

532

6776

M04AA01

ATC

allopurinol; systemic

0.8

8.3

558

7064

R2110

NOMESCO Finland

Giving the first information

1.6

8.3

229

1490

I87.1

ICD-10 Finland

Compression of vein

8.5

8.3

C76.1

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Thorax

10.7

8.3

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

8.3

1125

13177

L08

ICPC

Shoulder symptom/complaint

0.8

8.3

478

6168

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.4

8.2

108

S01ED51

ATC

timolol, combinations; ophthalmic

0.7

8.2

219

3188

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.1

1588

13861

M01AH05

ATC

etoricoxib; oral

0.8

8.1

1865

20861

8246/3-C34.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of lung, NOS

33.4

8.1

GBA35

NOMESCO Finland

Endoscopic insertion of stent into trachea

33.4

8.1

Z85.1

ICD-10 Finland

Personal history of malignant neoplasm of trachea, bronchus and lung

33.4

8.1

GD003

NOMESCO Finland

Adjuvant radiotherapy of trachea, bronchi and lungs

17.2

8.1

DFF15

NOMESCO Finland

Speech audiometry

0.6

8.0

1563

WW200

NOMESCO Finland

Immunization

1.9

8.0

109

576

HA1AA

NOMESCO Finland

X-ray mammography

1.6

8.0

225

1470

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

3.4

8.0

106

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.2

7.9

356

J45.8

ICD-10 Finland

Mixed asthma

1.8

7.9

133

752

R03BA01

ATC

beclometasone; inhalant

1.3

7.9

619

4874

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

13.0

7.9

GCA08

NOMESCO Finland

Bronchoscopic excsion of lesion of bronchus

13.0

7.9

R03AC03

ATC

terbutaline; inhalant

1.3

7.8

538

4154

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

5.1

7.8

S29

ICPC

Skin symptom/complaint other

0.8

7.8

441

5710

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

5.7

7.8

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.8

7.8

693

8489

GWW96

NOMESCO Finland

Other reoperation in thoracic surgery

9.4

7.8

I49.5

ICD-10 Finland

Sick sinus syndrome

0.6

7.8

1525

J01DA06

ATC

[U] cefuroxime; systemic

1.3

7.7

611

4813

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.7

7.7

395

5186

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

7.7

128

724

K80

ICPC

Cardiac arrhythmia NOS

0.6

7.7

138

2180

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

2.4

7.7

266

1CD02

NOMESCO Finland

3.1

7.7

131

T90

ICPC

Diabetes non-insulin dependent

0.8

7.7

825

9898

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

7.4

7.7

H81

ICPC

Excessive ear wax

0.8

7.7

553

6939

UJC01

NOMESCO Finland

Scopy of lower throat

2.5

7.7

238

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

7.6

181

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

2.9

7.6

152

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

3.9

7.6

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

7.6

253

1719

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

4.3

7.6

SPAT1260

SPAT

Consultation of another employee

0.8

7.6

496

6304

C39.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs

18.4

7.6

R92

ICPC

Neoplasm respiratory unspecified

25.0

7.6

8246/3-C34.1

ICD-O-3

Neuroendocrine carcinoma, NOS, of upper lobe, lung

25.0

7.6

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

3.7

7.5

M25.5

ICD-10 Finland

Pain in joint

0.8

7.5

678

8291

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.1

7.5

370

N02AA03

ATC

hydromorphone; systemic, rectal

4.3

7.5

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

1.9

7.5

103

548

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

1.7

7.5

144

853

N07BB01

ATC

disulfiram; oral

1.7

7.5

133

768

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

0.6

7.5

119

1927

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

0.4

7.4

882

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.8

7.4

549

6874

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

4.0

7.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

7.4

318

R00.1

ICD-10 Finland

Bradycardia, unspecified

0.5

7.4

1271

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.7

7.4

321

4316

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

7.4

126

2012

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.7

7.4

185

2727

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

2.4

7.4

249

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

7.4

274

1904

I44.1

ICD-10 Finland

Atrioventricular block, second degree

0.5

7.3

879

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

8.3

7.3

8072/3-C34.1

ICD-O-3

Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of upper lobe, lung

+∞

7.3

8260/3-C34.3

ICD-O-3

Papillary adenocarcinoma, NOS, of lower lobe, lung

+∞

7.3

3017

Kela drug reimbursment

Brigatinib

+∞

7.3

GCA40

NOMESCO Finland

Closure of bronchopleural fistula

+∞

7.3

8046/3-C34.0

ICD-O-3

Non-small cell carcinoma of main bronchus

+∞

7.3

8230/3-C34.3

ICD-O-3

Solid carcinoma, NOS, of lower lobe, lung

+∞

7.3

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

7.3

107

582

F06.7

ICD-10 Finland

Mild cognitive disorder

0.5

7.3

906

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.7

7.3

280

3831

H40.0

ICD-10 Finland

Glaucoma suspect

0.7

7.2

160

2420

C34.06

ICD-10 Finland

Malignant tumor of the main bronchial microcellular carcinoma

5.4

7.2

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.8

7.2

451

5762

-1

NOMESCO Finland

0.8

7.2

781

9365

A10BK01

ATC

dapagliflozin; oral

0.5

7.2

1057

S12

ICPC

Insect bite/sting

0.6

7.2

152

2317

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.4

7.2

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

2.4

7.2

247

GDA96

NOMESCO Finland

Other incision, excision of lesion or repair of lung

30.0

7.1

K77

ICPC

Heart failure

0.4

7.1

708

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.7

7.1

216

3074

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

0.7

7.1

260

3586

H25.0

ICD-10 Finland

Senile incipient cataract

0.7

7.1

167

2487

I48

ICD-10 Finland

Atrial fibrillation and flutter

0.8

7.0

1231

14126

1629X

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]

8.8

7.0

C09CA06

ATC

candesartan; oral

0.8

7.0

612

7516

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

0.7

7.0

198

2853

ZXC50

NOMESCO Finland

Cryotherapy

0.5

7.0

1044

1440

FHL

Mediastinoscopy

7.0

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.7

7.0

191

2768

H26.4

ICD-10 Finland

After-cataract

0.7

7.0

281

3817

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

6.3

6.9

R42

ICD-10 Finland

Dizziness and giddiness

0.8

6.9

735

8838

CJB10

NOMESCO Finland

Laser discission of secondary cataract

0.7

6.9

235

3281

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

7.5

6.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

6.9

777

9284

H91.1

ICD-10 Finland

Presbycusis

0.7

6.9

198

2844

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1.8

6.9

113

640

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

4.8

6.8

WX734

NOMESCO Finland

JET-ventilation

8.2

6.8

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

2.3

6.8

253

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

0.5

6.8

953

U04

ICPC

Incontinence urine

0.6

6.8

1522

R03AC19

ATC

olodaterol; inhalant

3.2

6.8

104

I50.1

ICD-10 Finland

Left ventricular failure

0.7

6.8

167

2469

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.0

6.8

416

M54.5

ICD-10 Finland

Low back pain

0.8

6.8

886

10438

SPAT1216

SPAT

Assessment of functional ability

0.8

6.8

540

6700

GDC23

NOMESCO Finland

Lobectomy and segment resection of lung

40.1

6.8

1623F

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,MUU HISTOLOGIA]

40.1

6.8

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

5.6

6.7

1623E

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA ALIA DEF/NUD]

16.7

6.7

I35.0

ICD-10 Finland

Aortic (valve) stenosis

0.7

6.7

205

2916

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.0

6.7

369

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

4.3

6.7

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

7.2

6.7

114

Kela drug reimbursment

Glaucoma

0.7

6.7

303

4044

M76.6

ICD-10 Finland

Achilles tendinitis

0.5

6.7

1014

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

6.4

6.6

SPAT1101

SPAT

Orthostatic test

0.6

6.6

107

1724

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

7.8

6.6

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.8

6.6

536

6634

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

1.8

6.6

103

573

C08CA02

ATC

felodipine; oral

0.7

6.6

339

4443

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.5

6.6

195

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

0.6

6.5

114

1805

M05BA02

ATC

clodronic acid; systemic

2.8

6.5

134

A02BX05

ATC

bismuth subcitrate; oral

1.9

6.5

489

XG466

NOMESCO Finland

Sleep oxymetry

1.6

6.5

151

942

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

5.0

6.5

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

3.6

6.5

H25.8

ICD-10 Finland

Other senile cataract

0.8

6.5

414

5274

B35.1

ICD-10 Finland

Tinea unguium

0.6

6.4

1504

E83.50

ICD-10 Finland

Hypercalcemia

2.2

6.4

260

1629C

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]

69.9

6.4

8012/3-C34.9

ICD-O-3

Large cell carcinoma, NOS, of lung, NOS

69.9

6.4

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

1.9

6.4

455

ZX100

NOMESCO Finland

Oral

2.0

6.4

363

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

7.4

6.4

GA3CT

NOMESCO Finland

Pleural cytology with CT guidance

14.3

6.4

G30

ICD-10 Finland

Alzheimer disease

0.3

6.4

413

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

4.0

6.4

A10BA02

ATC

metformin; oral

0.8

6.4

1183

13520

J94.9

ICD-10 Finland

Pleural condition, unspecified

2.7

6.3

144

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

0.5

6.3

1135

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

0.7

6.3

174

2521

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

6.3

350

2621

L02BB03

ATC

bicalutamide; oral

0.6

6.3

107

1707

SPAT1324

SPAT

Screening procedure

0.7

6.3

139

2099

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.9

6.3

495

4040

NOMESCO Finland

11.0

6.3

S82

ICPC

Naevus/mole

0.7

6.3

256

3470

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

0.7

6.3

179

2576

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

0.6

6.3

1363

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

9.2

6.3

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

18.0

6.3

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

6.3

374

8012/3-C34.3

ICD-O-3

Large cell carcinoma, NOS, of lower lobe, lung

+∞

6.2

8010/3-C34.2

ICD-O-3

Carcinoma, NOS, of middle lobe, lung

+∞

6.2

8551/3-C34.9

ICD-O-3

Acinar cell cystadenocarcinoma of lung, NOS

+∞

6.2

8140/2-C34.3

ICD-O-3

Adenocarcinoma in situ, NOS, of lower lobe, lung

+∞

6.2

3026

Kela drug reimbursment

Lorlatinib

+∞

6.2

AS4

Physiological pacemaker insertion DDD (R)

0.4

6.2

554

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

0.2

6.2

321

N19

ICD-10 Finland

Unspecified kidney failure

0.6

6.2

1425

GD3CT

NOMESCO Finland

Labeling lungs with CT guidance

26.7

6.2

SGA01

NOMESCO Finland

Tooth opening as first aid

0.7

6.2

224

3097

R01AD12

ATC

fluticasone furoate; nasal

0.8

6.2

575

7018

I50

ICD-10 Finland

Heart failure

0.6

6.2

1258

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

0.7

6.2

171

2474

SFA40

NOMESCO Finland

Replacement of krone of tooth

0.8

6.2

559

6842

C08CA01

ATC

amlodipine; oral

0.9

6.2

1576

17580

I44.2

ICD-10 Finland

Atrioventricular block, complete

0.6

6.2

1166

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

0.7

6.2

190

2697

F05.1

ICD-10 Finland

Delirium superimposed on dementia

0.1

6.2

235

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

6.2

462

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

6.2

246

1738

GAC46

NOMESCO Finland

Partial decortication of pleura

5.0

6.2

OAB43

SPAT

0.6

6.2

1269

RS220

NOMESCO Finland

2.3

6.1

232

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.3

6.1

222

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

1.7

6.1

110

642

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.2

6.1

254

I20.01

ICD-10 Finland

Unstable angina

0.6

6.1

1303

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

0.3

6.1

418

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

1.8

6.0

533

L02AE02

ATC

leuprorelin; implant, parenteral

0.7

6.0

178

2547

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

920

694

15.21

307.65

1.8

17.9

25.3

ug/l

2.33

913

674

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1707

6074

3.43

307.65

3.7

4.0

58.2

21.3

ug/l

2.42

1561

5013

(4035726)

2217

4323

7.18

307.65

1.5

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1041

1279

9.46

307.65

1.4

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1093

639

20.26

307.65

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

462

510

9.66

307.65

1.6

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1083

2103

5.95

307.65

2.3

2.6

—

(3042631) Mycobacterium sp identified in Specimen

538

848

6.81

307.65

1.9

2.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

592

1117

5.72

301.08

1.3

—

(40768806) Pleura Pathology biopsy report

482

777

6.61

287.72

1.5

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1977

8897

2.74

278.46

4.4

3.0

0.8

mmol/l

25.68

1919

8196

(3003434) Protein [Mass/volume] in Pleural fluid

539

1015

5.69

274.20

1.4

1.5

39.0

30.3

g/l

44.87

506

888

(3023199) Leukocytes [#/volume] in Pleural fluid

483

873

5.89

256.38

1.4

1.5

2501.3

1617.7

e6/l

1.62

354

610

(3028308) Erythrocytes [#/volume] in Pleural fluid

452

794

6.03

247.02

1.4

1.5

65496.4

78224.3

e6/l

0.22

279

456

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1128

3992

3.20

243.40

5.7

2.1

425.8

369.9

nmol/l

13.60

1089

3602

(3012441) Differential panel - Pleural fluid

434

786

5.84

229.51

1.4

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

390

695

5.90

209.53

1.3

634.5

388.0

u/l

1.63

381

654

(3036782) Glucose [Moles/volume] in Pleural fluid

367

673

5.71

191.10

1.3

1.4

5.8

6.4

mmol/l

2.59

346

616

(3045788) Cell count panel - Pleural fluid

364

675

5.65

187.24

1.4

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

326

544

6.25

187.13

1.2

1.3

11.5

13.6

u/l

0.96

316

488

(4010399)

938

3445

3.00

186.80

1.4

—

(42870588) Differential panel, method unspecified - Blood

2811

17260

2.09

176.60

7.0

5.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1478

7048

2.41

173.55

4.4

3.9

243.1

248.5

u/l

0.64

1442

6582

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3378

45021

0.49

167.47

3.9

4.8

1.4

mmol/l

2.25

2892

40258

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3434

45499

0.50

166.79

3.9

4.8

4.5

4.4

mmol/l

2.86

2980

41039

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3588

46828

0.49

165.84

4.4

5.4

2.6

2.5

mmol/l

4.21

3070

42020

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3351

44609

0.50

161.97

5.8

6.7

41.2

41.1

mmol/mol

0.25

2933

40311

(3022096) Basophils/100 leukocytes in Blood

3321

22303

1.97

156.16

7.3

5.7

0.6

2.98

3244

20480

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3291

43594

0.52

147.43

3.6

4.3

1.3

mmol/l

4.69

2789

38602

(3019069) Monocytes/100 leukocytes in Blood

3367

23042

1.93

146.35

7.5

6.1

9.1

9.0

1.24

3290

21205

(3006504) Eosinophils/100 leukocytes in Blood

3351

22932

1.93

145.29

7.4

5.7

2.5

2.9

24.60

3276

21036

(3009214) Lutropin [Units/volume] in Serum or Plasma

316

661

4.97

141.56

1.3

14.4

11.0

u/l

2.87

260

526

(3002030) Lymphocytes/100 leukocytes in Blood

3384

23421

1.90

139.80

7.5

5.9

22.4

25.9

62.13

3299

21381

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

270

504

5.54

137.55

1.3

1.4

10.7

13.7

u/l

11.85

259

483

(3001604) Monocytes [#/volume] in Blood

3458

24241

1.88

135.85

7.2

5.4

0.7

0.6

e9/l

35.81

2989

20511

(3013650) Neutrophils [#/volume] in Blood by Automated count

3875

28253

1.88

133.69

15.5

8.5

4.9

4.3

e9/l

28.78

3444

24355

(3006315) Basophils [#/volume] in Blood

3468

24418

1.87

133.51

7.2

5.4

0.0

e9/l

5.22

3001

20689

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1629

8900

2.10

132.76

2.1

2.0

29.9

30.3

2.02

1603

8621

(3018010) Neutrophils/100 leukocytes in Blood

3303

23021

1.86

130.11

7.3

5.7

62.1

58.7

46.66

3223

21148

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

809

3312

2.64

128.63

7.1

6.6

25.8

24.7

mmol/l

16.74

803

3279

(3019198) Lymphocytes [#/volume] in Blood

3484

24795

1.85

127.30

7.3

5.5

1.7

1.9

e9/l

2.84

3055

21343

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

251

476

5.44

125.61

1.2

1.3

—

(3013115) Eosinophils [#/volume] in Blood

3516

25160

1.84

125.53

7.5

5.6

0.2

e9/l

1.90

3070

21613

(3035880) pH of Pleural fluid

230

406

5.83

124.31

1.2

1.3

—

(3018418) pH of Serum or Plasma

2517

16280

1.88

124.01

5.5

4.1

7.4

1.36

456

3126

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3689

46247

0.55

120.15

5.1

5.2

6.2

6.1

mmol/l

0.88

3231

41003

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

776

3239

2.58

118.11

8.5

8.0

25.0

24.2

mmol/l

13.07

755

2945

(3023368) Bacteria identified in Blood by Culture

2583

17055

1.84

117.52

4.9

4.4

—

(3032080) INR in Blood by Coagulation assay

3349

23925

1.80

117.17

7.4

11.4

1.2

1.4

inr

18.74

710

6588

(3033658) Prothrombin time (PT) actual/Normal

2077

13015

1.86

110.19

5.5

4.0

92.4

83.0

61.20

2052

12672

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3690

27492

1.76

108.40

11.2

6.1

9.7

12.5

umol/l

28.02

3619

25962

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

158

221

7.30

106.95

1.3

1.4

26.5

34.4

u/l

1.88

153

176

(40768804) Tissue Pathology biopsy report

2809

19469

1.76

105.27

2.8

2.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

4324

51286

0.56

105.24

43.1

26.0

126.2

133.2

g/l

161.51

4251

50174

(3010813) Leukocytes [#/volume] in Blood

4325

51293

0.56

105.20

42.8

25.8

8.1

7.0

e9/l

53.73

4175

49345

(3026361) Erythrocytes [#/volume] in Blood

4324

51278

0.56

105.00

42.8

25.8

4.3

4.4

e12/l

64.39

4174

49319

(3035941) MCH [Entitic mass]

4324

51276

0.56

104.94

42.6

25.7

30.1

30.5

34.83

4243

50161

(3024731) MCV [Entitic volume]

4324

51275

0.56

104.91

42.7

25.7

91.6

91.8

2.84

4244

50164

(3007461) Platelets [#/volume] in Blood

4324

51267

0.56

104.68

42.9

25.8

272.1

237.0

e9/l

144.45

4197

49537

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3415

25154

1.73

101.95

8.2

6.0

1.2

mmol/l

10.30

3275

22475

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

261

624

4.31

98.84

3.0

3.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1714

10467

1.86

96.42

5.6

3.1

2.5

mmol/l

57.53

1585

9018

(3023419) Bacteria identified in Sputum by Culture

282

729

3.99

96.14

1.8

2.5

—

(3003396) Base excess in Arterial blood by calculation

1277

7102

1.99

95.21

7.6

6.5

1.5

1.1

mmol/l

4.67

1105

5409

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1278

7136

1.98

94.07

7.6

6.5

5.4

5.0

kpa

25.53

1224

6738

(3027801) Oxygen [Partial pressure] in Arterial blood

1276

7134

1.97

93.52

7.6

6.5

11.5

11.8

kpa

1.76

1220

6726

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3630

27597

1.69

92.89

9.4

6.8

1.2

mmol/l

4.04

3136

22989

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1692

25326

0.56

91.11

4.5

5.5

2.4

4.4

ug/l

9.07

1440

22264

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2206

14819

1.73

88.31

4.5

3.2

31.0

37.5

u/l

2.68

2142

13891

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

703

3190

2.35

88.00

9.5

9.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

139

218

6.49

84.56

1.2

1.3

3.6

3.5

mmol/l

0.23

132

191

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4250

49769

0.60

81.46

19.8

11.2

24.1

25.4

u/l

4.63

4179

47400

(3023103) Potassium [Moles/volume] in Serum or Plasma

4314

50273

0.60

79.98

32.7

21.2

4.0

mmol/l

0.80

4215

48754

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1278

20167

0.55

79.29

4.0

4.8

20.5

22.2

4.14

625

10815

(3019550) Sodium [Moles/volume] in Serum or Plasma

4315

50201

0.60

77.98

32.6

21.0

138.4

139.6

mmol/l

124.70

4226

48757

(3014111) Lactate [Moles/volume] in Serum or Plasma

979

5289

2.00

77.92

7.3

6.1

1.2

1.4

mmol/l

8.12

942

5024

(3016502) Oxygen saturation in Arterial blood

1115

6372

1.90

74.92

8.2

6.8

95.1

95.2

0.19

1085

6124

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3516

42761

0.62

74.49

5.9

4.6

1.9

2.1

mu/l

2.69

3135

37930

(3015377) Calcium [Moles/volume] in Serum or Plasma

2513

18121

1.62

73.13

5.7

3.3

2.4

2.3

mmol/l

17.05

2338

15335

(3042936) Bacteria identified in Isolate by Culture

1297

7829

1.81

73.01

1.9

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

130

222

5.95

72.66

1.2

680.7

289.0

ug/l

1.00

110

104

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1888

12684

1.68

72.59

2.6

2.5

—

(40758558) Short blood count panel - Blood

1855

12414

1.68

72.33

11.4

6.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1016

5712

1.92

71.47

8.7

7.3

120.8

119.9

g/l

0.75

989

5515

(3024561) Albumin [Mass/volume] in Serum or Plasma

3119

23904

1.57

68.71

6.2

4.8

32.9

34.4

g/l

36.29

2978

21900

(3001893) Eosinophils/100 leukocytes in Pleural fluid

131

240

5.55

68.00

1.3

1.4

4.8

2.3

1.59

120

195

(40761511) CBC panel - Blood by Automated count

4137

48160

0.63

67.64

25.7

17.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1541

9969

1.71

67.43

2.0

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

691

12521

0.50

64.30

1.6

1.4

1.3

mmol/l

1.22

585

10293

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

141

291

4.93

64.02

1.3

1.4

65.1

68.7

0.58

124

226

(3000991) Gas panel - Venous blood

887

4963

1.91

62.71

8.4

7.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

195

527

3.78

62.36

1.3

31.3

36.1

iu/l

1.01

152

448

(3002256) Pathology report gross observation

1119

6782

1.78

61.01

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

2294

16733

1.56

60.55

2.7

2.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

113

205

5.59

59.30

1.3

1.4

16.2

21.6

1.33

108

184

(3014576) Chloride [Moles/volume] in Serum or Plasma

1192

7456

1.73

57.88

7.8

6.4

104.0

104.5

mmol/l

2.95

1165

7286

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

104

179

5.89

57.68

1.3

1.4

19.2

21.0

0.27

138

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

163

413

4.02

57.07

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

491

2331

2.19

54.29

2.3

2.8

0.3

u/ml

0.73

266

1337

(3009508) Creatinine [Moles/volume] in Urine

1154

17308

0.60

53.45

2.9

3.2

7.2

7.3

mmol/l

0.48

904

14161

(3020682) Albumin/Creatinine [Ratio] in Urine

1226

18104

0.60

53.25

3.8

4.0

11.3

9.8

mg/mmol

0.49

779

11578

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1736

23665

0.64

53.14

1.9

2.1

89.5

92.1

pmol/l

1.59

921

12491

(3012516) Albumin [Mass/volume] in Urine

1141

17094

0.60

52.36

3.0

3.3

468.0

349.0

mg/l

0.38

751

11048

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1091

6850

1.71

51.68

2.0

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

319

1280

2.57

51.64

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

328

1334

2.53

51.62

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

534

2681

2.08

51.01

2.0

1.9

2.7

ug/l

0.73

486

2311

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

901

14253

0.57

50.80

3.0

3.3

0.8

ug/l

0.13

625

10311

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1090

6887

1.70

50.32

2.0

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

963

2.77

49.33

1.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3833

44365

0.68

48.87

29.5

16.8

77.3

72.4

ml/min/173m2

45.62

3457

36796

(3000492) Spirometry study

668

3694

1.90

48.28

1.6

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

240

872

2.82

47.22

1.5

1.7

3.1

4.6

iu/l

1.49

262

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

258

984

2.69

46.25

1.5

1.6

—

(1761868) Lipid panel - Serum or Plasma

838

13048

0.59

43.16

3.1

3.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

794

2.79

42.14

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

229

867

2.70

41.65

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

209

765

2.79

40.57

1.5

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1485

19973

0.67

38.65

2.0

2.2

76.2

79.0

nmol/l

2.98

1298

17303

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

355

1740

2.10

35.94

1.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

204

787

2.64

35.77

1.6

1.5

—

(3019060) Gas panel - Arterial blood

692

4235

1.71

35.11

4.5

4.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

7.07

34.69

1.3

1.4

81.9

74.4

1.02

(3013826) Glucose [Moles/volume] in Serum or Plasma

3669

31389

1.37

34.41

7.5

4.9

6.8

6.9

mmol/l

4.62

3571

29534

(3021589) Normoblasts [#/volume] in Blood

2605

21167

1.38

33.31

14.4

10.4

0.0

e9/l

0.91

2038

17173

(44786800) Granulocytes/100 leukocytes in Body fluid

100

5.84

32.19

1.3

18.6

16.9

0.18

(3003338) MCHC [Mass/volume]

3210

37116

0.74

31.13

39.4

23.3

328.1

331.6

g/l

85.56

3165

36651

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

729

4673

1.63

30.76

2.8

2.3

33.1

38.0

u/l

1.38

643

3945

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1411

18551

0.70

30.55

3.9

4.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2953

34511

0.74

30.44

5.1

3.8

15.3

15.0

pmol/l

4.43

2681

30460

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

607

3736

1.69

29.97

1.8

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

385

2073

1.91

29.85

1.9

2.2

365.2

676.3

ug/l

1.02

348

1965

(3006184) Hemoglobin [Mass/volume] in Capillary blood

284

1387

2.09

29.02

2.0

2.3

121.3

126.9

g/l

2.17

152

1012

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4308

47509

0.74

28.97

31.8

17.6

37.8

27.8

mg/l

60.24

4124

39033

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

869

12406

0.66

28.64

1.6

1.7

15616504.9

28115083.9

pmol/l

0.35

698

9977

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

165

649

2.58

27.88

1.6

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

219

985

2.26

27.53

3.6

61.9

58.6

2.94

219

985

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

143

528

2.75

27.39

1.3

1.6

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

110

352

3.16

27.22

4.0

3.7

136.7

159.8

nmol/l

0.30

110

347

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1478

11242

1.40

26.90

4.8

4.2

304.5

503.3

ng/l

1.11

1302

9700

(3019150) Specific gravity of Urine by Refractometry

754

10939

0.65

26.57

3.9

4.4

1.0

kg/l

0.01

115

1706

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

136

502

2.74

26.08

1.3

1.6

—

(3012501) Base excess in Blood by calculation

274

1378

2.03

25.87

4.5

4.6

3.0

2.7

mmol/l

1.12

217

922

(3041918) Cholesterol [Moles/volume] in Pleural fluid

126

4.72

25.87

1.2

2.0

1.4

mmol/l

2.97

(3013290) Carbon dioxide [Partial pressure] in Blood

274

1379

2.03

25.82

4.5

4.6

5.1

5.0

kpa

1.56

269

1345

(3027315) Oxygen [Partial pressure] in Blood

275

1386

2.03

25.81

4.5

4.6

8.1

8.4

kpa

2.05

270

1351

(3009261) Glucose [Presence] in Urine by Test strip

2016

24494

0.75

25.13

3.6

4.0

0.0

estimate

1.34

430

4457

(3035350) Ketones [Presence] in Urine by Test strip

1986

24148

0.75

24.77

3.5

3.9

0.0

estimate

0.00

447

4542

(1616796) Gas panel - Central venous blood

276

1414

1.99

24.75

3.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

411

2.88

24.64

1.7

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

106

355

3.02

24.31

1.7

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1992

24166

0.75

24.29

4.8

5.2

0.0

estimate

0.00

453

4584

(3020630) Protein [Mass/volume] in Serum or Plasma

782

5366

1.52

24.22

1.8

2.5

65.0

65.9

g/l

2.54

725

4797

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

106

356

3.01

24.19

1.7

1.5

—

(3010421) pH of Blood

297

1584

1.92

23.69

4.6

4.4

7.4

1.35

269

1347

(3009542) Hematocrit [Volume Fraction] of Blood

3616

40443

0.77

23.63

32.3

19.0

37.8

38.5

4.85

2343

24639

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

587

3798

1.60

23.60

4.0

3.7

2.6

1.8

mmol/l

5.28

484

2765

(3009343) pH of Capillary blood

603

3929

1.59

23.53

4.1

3.7

7.4

0.33

483

(3021960) Folate [Moles/volume] in Serum or Plasma

1044

13945

0.70

23.40

1.5

1.6

20.1

19.8

nmol/l

0.21

912

11787

(3017181) Myelocytes/100 leukocytes in Blood

666

4453

1.55

23.20

3.1

3.9

1.3

1.0

1.70

328

1363

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

606

3985

1.57

22.71

4.1

3.7

5.3

5.1

kpa

3.00

574

3652

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

124

4.46

22.60

1.4

1.5

11.0

5.6

0.98

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

124

474

2.65

22.27

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

124

474

2.65

22.27

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

124

474

2.65

22.27

1.3

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

550

3557

1.60

22.12

1.6

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2763

23632

1.29

21.55

4.2

4.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

151

650

2.35

21.10

2.6

4.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2006

16486

1.31

21.07

4.7

2.5

58.8

59.4

u/l

0.18

1911

15134

(3021440) Promyelocytes/100 leukocytes in Blood

625

4217

1.53

20.82

3.1

3.9

0.2

0.1

0.72

304

1259

(3026493) Urate [Moles/volume] in Serum or Plasma

1093

14248

0.72

20.71

2.7

2.9

4104.9

6019.0

umol/l

0.85

901

12007

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

259

1385

1.91

20.52

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

259

1385

1.91

20.52

1.2

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

125

502

2.52

20.33

1.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1038

13592

0.72

20.13

4.0

4.3

0.0

estimate

0.35

393

4298

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

347

2.82

19.83

2.8

3.9

—

(44790049)

134

563

2.41

19.79

1.5

1.4

—

(44790048)

134

563

2.41

19.79

1.5

1.4

—

(44790047)

134

563

2.41

19.79

1.5

1.4

—

(44806118)

134

563

2.41

19.79

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

204

1019

2.03

19.69

2.2

3.7

1.5

1.6

0.11

176

759

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

143

3.94

19.60

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

340

2.82

19.42

1.0

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

591

4000

1.52

19.36

3.1

3.8

0.7

0.06

245

955

(3019309) Folate [Moles/volume] in Red Blood Cells

951

12554

0.72

19.25

1.8

1069.7

1156.3

nmol/l

2.11

715

9289

(3037692) Legionella sp identified in Specimen by Organism specific culture

183

3.52

19.04

1.3

—

(3022313) Gas panel - Capillary blood

444

2839

1.60

18.68

4.4

3.9

—

(40767503) Oxygen content in Capillary blood by calculation

243

1323

1.87

18.24

2.6

14.8

15.8

2.62

118

702

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

468

6973

0.65

18.04

11.7

8.3

—

(3051651) Icteric interference index of Serum or Plasma

328

2.77

17.81

4.4

3.6

—

(3021901) Oxygen saturation in Capillary blood

228

1245

1.86

16.98

2.9

2.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

254

1445

1.79

16.56

3.0

2.9

7.7

7.8

kpa

0.30

240

1331

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

387

2.50

15.59

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1650

19693

0.78

15.59

2.6

2.9

228.3

165.2

ug/l

8.29

1502

17683

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

464

6726

0.67

15.51

3.6

4.9

33.0

33.2

0.10

298

4352

(3037467) Urinalysis macro (dipstick) panel - Urine

3133

34757

0.81

14.86

4.3

4.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1140

9033

1.32

14.82

2.9

3.2

2.3

1.8

e6/l

1.18

612

5215

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

124

583

2.15

14.16

2.7

3.8

38.6

32.4

u/ml

0.34

118

566

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.11

14.08

1.1

—

(3044889) 12 lead EKG panel

3163

34950

0.82

14.00

4.9

4.4

—

(3025159) Blasts/100 leukocytes in Blood

550

3922

1.44

13.78

3.3

4.0

0.0

0.3

1.43

266

1045

(3002385) Erythrocyte distribution width [Ratio]

3414

37370

0.82

13.43

37.6

21.4

14.5

13.9

81.00

3369

36382

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

328

2113

1.58

13.40

2.7

3.3

730.6

2738.5

u/ml

0.83

279

1801

(36304419) Bacteria [Presence] in Urine

1763

14931

1.25

13.19

3.2

3.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

213

2.88

13.17

1.2

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

213

2.88

13.17

1.2

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

1843

15692

1.24

13.12

3.2

3.4

0.6

0.5

e6/l

1.53

1395

12110

(3000494) Fungus identified in Specimen by Culture

745

5639

1.36

13.12

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

216

2.84

12.85

1.2

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

579

4221

1.41

12.81

1.5

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

625

8319

0.73

12.74

1.2

2.4

1.9

u/ml

0.37

115

2072

(3015235) Bicarbonate [Moles/volume] in Capillary blood

272

1698

1.63

12.67

3.3

3.1

25.7

24.8

mmol/l

2.70

242

1469

(3052851) Hemolysis interference index of Serum or Plasma

271

1691

1.63

12.65

3.9

3.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

195

1115

1.77

12.58

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

283

2.56

12.41

1.2

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

283

2.56

12.41

1.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

283

2.56

12.41

1.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

283

2.56

12.41

1.2

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

1998

17273

1.22

12.11

3.2

3.5

79.4

109.6

e6/l

0.70

1547

13623

(3014891) Appearance of Pleural fluid

121

3.40

11.75

1.5

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

202

1197

1.71

11.52

1.9

2.3

220.9

208.2

1.36

191

1140

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

4.66

11.39

1.0

1.1

41.1

7.4

iu/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1024

12536

0.78

11.25

3.6

3.7

—

(3026782) Osmolality of Urine

1376

11537

1.24

10.97

2.7

3.0

537.4

557.6

mosm/kgh2o

2.90

1206

9835

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

3.58

10.88

5.8

4.1

29.4

41.6

u/l

1.33

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

375

2610

1.46

10.69

1.9

2.0

—

(40768795) Lymph node Pathology biopsy report

478

2.09

10.66

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

161

919

1.77

10.52

4.2

4.8

347.1

3167.1

iu/ml

0.84

136

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

343

2386

1.46

9.83

4.8

4.1

25.6

24.7

mmol/l

6.24

328

2159

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

387

2.16

9.81

2.4

3.7

41.4

45.1

u/ml

0.11

382

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

292

4242

0.67

9.76

1.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

252

1647

1.55

9.75

2.6

4.0

69.0

73.6

u/ml

0.10

242

1581

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1233

10346

1.24

9.62

1.6

1.7

1.9

1.5

mg/l

1.81

1036

8089

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

314

2.27

9.55

1.9

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

113

598

1.90

9.45

4.2

3.4

—

(40761535) Cells panel - Urine sediment

344

4818

0.70

9.43

3.6

—

(3036489) Thrombin time

254

1687

1.53

9.15

1.7

1.9

21.7

0.01

235

1518

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

269

3919

0.67

9.13

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

169

1021

1.67

9.06

1.3

58.8

63.1

mmol/l

0.71

132

824

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

211

1349

1.58

9.01

1.9

2.2

4.1

3.6

g/l

3.41

203

1273

(40758047) Lysozyme [Mass/volume] in Pleural fluid

3.71

8.87

1.2

6.6

8.8

mg/l

0.61

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

161

2.74

8.84

1.3

1.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

386

2805

1.40

8.72

2.6

3.9

24.6

24.0

mmol/l

2.38

367

2496

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4175

39242

1.17

8.54

15.7

7.6

86.6

81.6

u/l

9.16

4100

36576

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

604

4716

1.31

8.53

5.5

4.0

1.2

mmol/l

2.95

570

4086

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1135

9568

1.22

8.37

2.9

3.0

1.0

1.2

e6/l

0.78

607

5708

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

173

2.61

8.24

1.2

2.0

2357.5

20047.8

u/ml

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

726

5834

1.27

8.21

2.5

2.7

8.7

9.6

umol/l

0.37

638

5083

(3013512) EKG study

1456

16714

0.84

8.20

4.6

4.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

113

629

1.81

8.13

2.2

3.5

56.4

59.8

0.77

381

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.47

8.07

1.2

21.6

18.1

u/l

0.43

(3009445) Proteinase 3 Ab [Units/volume] in Serum

322

2311

1.41

7.85

1.4

1.6

16.5

18.6

u/ml

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

562

4397

1.30

7.82

1.3

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

511

3950

1.32

7.77

7.8

6.7

25.5

24.4

mmol/l

10.32

483

3694

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

333

2409

1.40

7.76

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

700

5646

1.27

7.67

4.4

6.7

8.6

11.5

mmol/l

25.56

668

5309

(3011397) Hemoglobin [Presence] in Urine by Test strip

989

11704

0.82

7.62

3.2

3.8

—

(3011412) CD3 cells [#/volume] in Blood

422

1.95

7.54

1.7

2.0

0.9

1.1

e9/l

1.84

260

(3024891) Influenza virus A+B Ag [Presence] in Specimen

176

1129

1.57

7.48

1.2

—

(3028433) Virus identified in Specimen by Culture

160

2.57

7.32

1.1

1.2

—

(4034850)

1621

0.57

6.93

12.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1129

9682

1.20

6.88

5.6

4.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

299

2.08

6.85

2.2

3.5

—

(3045414) Leukocytes [Presence] in Urine

149

2287

0.64

6.60

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1233

0.52

6.50

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1301

14821

0.85

6.44

2.2

2.3

3.3

3.1

mg/l

2.07

1116

12428

(3018095) Leukocytes [#/volume] in Urine

2131

19334

1.15

6.37

3.7

4.0

77.9

118.5

e6/l

1.64

1582

14437

(3039443) Prostate specific Ag panel - Serum or Plasma

804

0.42

6.33

1.3

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

525

6505

0.79

6.14

1.2

31.0

14.1

u/ml

0.87

148

2268

(21494814) CD8 cells/100 lymphocytes in Specimen

181

2.33

6.13

1.5

1.9

—

(4015189)

164

2.39

6.02

1.9

2.0

—

(3019977) pH of Arterial blood

364

1.90

5.99

2.4

7.4

0.95

140

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

569

6935

0.80

5.75

1.2

1.3

44.3

40.0

iu/ml

0.27

168

2099

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

110

1742

0.63

5.66

1.1

—

(3036603) Volume of Urine

344

1.90

5.61

1.2

1.7

2127.7

1801.0

1.02

(3048689) Calprotectin [Mass/mass] in Stool

351

4507

0.77

5.49

1.9

2.1

169.9

163.4

ug/g

0.10

273

3475

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.82

5.39

1.1

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

305

2314

1.33

5.37

3.9

3.2

4.3

pmol/l

0.93

283

1989

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

201

2787

0.71

5.28

2.3

2.4

20.5

23.9

au/ml

0.19

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

316

1.91

5.28

1.6

1.9

10.4

15.1

1.95

123

(3039000) Anion gap in Blood

189

1330

1.43

5.26

7.6

7.1

10.4

11.3

mmol/l

4.13

167

1196

(3018572) Chloride [Moles/volume] in Blood

189

1330

1.43

5.26

7.6

7.1

103.8

105.1

mmol/l

2.65

167

1196

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

178

2516

0.70

5.24

1.3

39.3

60.7

au/ml

—

(3045424) Erythrocytes [Presence] in Urine

863

0.50

5.21

1.4

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

311

1.91

5.18

1.5

1.9

—

(3002032) Base excess in Venous blood by calculation

685

5755

1.21

5.16

3.2

3.7

2.4

1.8

mmol/l

3.49

572

4598

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

286

1.93

5.04

1.9

2.1

498.5

588.4

e6/l

0.45

125

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

135

1991

0.67

5.01

1.7

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

684

5762

1.21

5.01

3.2

3.7

5.9

5.8

kpa

1.60

663

5559

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.89

4.98

1.1

1.0

0.1

g/l

0.06

(3004451) EKG impression Narrative

316

1.87

4.96

1.4

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3238

34268

0.89

4.95

4.5

4.9

194.3

1348.3

e6/l

3.71

613

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

389

1.78

4.93

1.1

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

635

7530

0.83

4.89

1.4

1.5

2.7

g/l

0.14

343

4303

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2622

28047

0.89

4.79

4.8

3.2

67.4

56.8

u/l

3.51

2429

25307

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

241

3176

0.75

4.60

2.7

2.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

226

3004

0.74

4.58

1.2

—

(3047181) Lactate [Moles/volume] in Blood

246

1856

1.34

4.55

7.2

6.2

1.1

1.4

mmol/l

5.78

218

1650

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

168

1193

1.42

4.51

1.8

11.6

12.6

mg/l

0.72

159

1085

(40768441) Liver Pathology biopsy report

323

1.80

4.36

1.2

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

279

2159

1.31

4.34

1.1

1.2

122.4

129.4

iu/ml

0.09

748

(3003458) Phosphate [Moles/volume] in Serum or Plasma

879

7683

1.17

4.21

4.4

5.7

1.0

mmol/l

2.38

830

7037

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2051

22085

0.90

4.01

2.6

2.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

10.01

4.01

1.1

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

302

2388

1.28

4.00

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

536

1.57

3.85

1.3

272.7

278.4

mosm/kgh2o

1.37

400

(3022621) pH of Urine by Test strip

281

3530

0.79

3.77

2.6

3.2

—

(21494755) Public health laboratory ask at order entry panel

1445

0.67

3.73

1.3

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

597

5109

1.19

3.72

2.0

2.1

0.2

g/l

0.91

553

4695

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

106

1538

0.68

3.71

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1020

0.61

3.70

1.1

1.3

39.2

39.3

u/l

0.00

874

(40768800) Prostate Pathology biopsy report

118

1676

0.70

3.68

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

568

0.49

3.62

1.4

—

(36660697) Celiac disease serology panel - Serum

234

2988

0.78

3.60

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

913

0.60

3.59

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

248

0.32

3.55

1.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

250

0.32

3.54

1.0

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

10.01

3.49

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

755

0.57

3.49

1.6

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

379

4561

0.82

3.44

2.1

2.3

—

(3008898) HLA-B27 [Presence]

897

0.61

3.37

1.0

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

244

1925

1.28

3.35

1.8

1.7

38.2

u/l

0.00

210

1629

(4146454)

682

0.55

3.35

2.5

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.83

3.35

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

298

1.72

3.34

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

298

1.72

3.34

1.2

1.4

—

(3000012) Reticulocyte production index

385

0.41

3.29

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1193

0.67

3.27

1.5

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

806

9072

0.87

3.24

23.2

29.9

1.4

1.5

inr

1.25

115

1239

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

724

1.44

3.22

1.8

2.3

307.1

1963.7

u/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

984

0.64

3.22

1.8

1.6

—

(4094501)

1295

0.68

3.22

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

258

1.75

3.16

2.2

2.5

41.8

36.2

0.70

101

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

168

1273

1.33

3.14

1.5

1.6

60.9

13.4

iu/ml

0.36

308

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1829

17030

1.10

3.09

2.4

2.2

143.9

225.5

u/l

10.99

1747

15823

(3046861) Legionella sp Ag [Presence] in Urine

3.24

3.05

1.2

1.0

—

(4024509)

568

0.54

2.98

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

233

1862

1.26

2.93

4.7

4.0

3.9

mmol/l

0.77

213

1736

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

558

1.48

2.89

1.1

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

296

1.66

2.89

1.1

1.2

29.0

27.9

u/l

0.05

251

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.47

2.78

1.3

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

166

1.87

2.75

1.4

1.5

69.8

125.2

umol/l

1.04

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.43

2.70

1.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

1.83

2.67

2.1

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

1.83

2.67

2.1

2.3

—

(3026008) Bacteria identified in Urine by Culture

1568

16803

0.91

2.58

3.0

3.4

—

(3000330) Specific gravity of Urine by Test strip

249

3024

0.82

2.55

3.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.73

2.54

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

341

0.47

2.49

1.3

1.8

—

70.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

677

0.63

2.37

1.5

70.4

62.8

0.85

430

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

251

1.64

2.35

1.2

1.4

0.4

1.5

u/ml

1.09

133

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

410

1.49

2.35

1.2

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

213

1.69

2.35

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

419

1.48

2.33

1.2

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

301

2542

1.19

2.29

6.1

5.2

0.9

0.73

278

2395

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

356

1.52

2.29

1.1

1.2

191.8

100.3

titre

0.36

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

305

2584

1.19

2.24

6.0

5.1

1.9

1.6

3.05

281

2431

(3008536) Aspergillus sp Ab [Presence] in Serum

107

1.97

2.20

1.2

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

280

1.58

2.19

2.0

439.4

493.6

e6/l

0.39

239

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

528

0.60

2.18

1.4

2.0

2.1

1.8

u/field

0.09

201

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

112

850

1.32

2.18

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

121

1562

0.77

2.16

1.5

—

(3017569) Oxygen content in Arterial blood

337

1.52

2.15

2.4

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

611

1.38

2.15

1.1

1.3

0.6

0.7

nmol/l

0.70

582

(44816559) Phosphatidylethanol [Mass/volume] in Blood

644

0.65

2.09

1.1

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

615

1.37

2.08

1.1

1.3

0.1

0.3

nmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

206

0.44

2.06

1.0

1.5

5.6

9.0

ug/l

—

180

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

959

0.72

2.05

2.1

1.4

1.1

0.8

nmol/l

0.69

789

(3019832) Treponema pallidum Ab [Presence] in Serum

1211

0.75

2.05

1.2

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

139

1.80

2.04

1.6

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

327

1.50

2.00

1.5

1.6

4.2

6.6

u/l

0.80

152

(3000034) Microalbumin [Mass/volume] in Urine

551

0.63

1.99

2.1

3.1

15.9

47.8

mg/l

2.04

421

(3007853) Bacteria identified in Skin by Aerobe culture

687

6227

1.12

1.96

1.6

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

1317

12322

1.09

1.94

2.6

2.7

6.0

4.3

e6/l

4.54

1175

10799

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.75

1.93

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.75

1.93

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

218

1.61

1.93

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

547

1.38

1.92

1.1

1.2

61.4

64.0

u/l

0.12

367

(3000570) Elastase.pancreatic [Mass/mass] in Stool

122

1541

0.79

1.88

1.3

1.5

268.7

260.4

ug/g

0.16

939

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

1.86

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.65

1.86

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

143

0.35

1.86

4.0

8.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

394

0.58

1.86

1.1

2.7

2.4

u/ml

—

106

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

649

0.68

1.85

1.0

1.1

10.9

307.6

iu/ml

—

125

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

906

0.73

1.85

2.4

3.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.12

1.81

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

786

0.71

1.81

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

223

1.57

1.78

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

131

1.76

1.77

2.1

2.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

1.74

1.0

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

439

3908

1.13

1.73

1.3

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

147

1.70

1.73

3.4

2.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

233

1.55

1.72

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

718

0.71

1.69

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

1.69

0.0

4.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

422

3756

1.13

1.68

1.3

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

219

1858

1.18

1.67

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

258

2222

1.17

1.64

1.2

1.3

251.4

242.7

u/ml

0.07

235

2022

(3024354) Oxygen [Partial pressure] in Venous blood

523

4724

1.12

1.63

3.0

3.1

4.5

4.4

kpa

0.07

505

4533

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

3.57

1.61

3.6

1.7

2.3

mg/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.00

1.58

4.5

5.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

123

1515

0.81

1.57

2.2

2.3

76.7

108.5

ug/min

1.11

879

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1093

0.77

1.56

1.4

—

(3006270) Folate [Moles/volume] in Blood

519

0.67

1.56

1.2

290.1

326.4

nmol/l

0.53

398

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

613

0.70

1.56

2.0

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

542

0.68

1.55

1.5

1.3

427624.9

144767.2

e6/l

0.56

367

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

516

0.68

1.52

1.5

1.4

20.8

25.9

0.52

324

(3022145) Colonoscopy Study observation

495

5460

0.90

1.51

1.3

—

(4198724)

2.16

1.50

1.5

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.16

1.50

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.16

1.50

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.16

1.50

1.4

1.2

—

(3025577) Chromium [Mass/volume] in Blood

406

0.64

1.49

1.8

2.0

2.4

2.1

ug/l

0.37

336

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.37

1.45

1.1

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.79

1.42

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1100

0.79

1.42

1.3

1.5

—

(3020891) Body temperature

279

2448

1.15

1.42

5.3

4.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1209

0.80

1.41

1.4

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.18

1.39

1.0

1.8

—

(1002224) Polysomnography panel

1140

0.80

1.38

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

109

1337

0.81

1.37

1.6

34165.6

14350.4

e6/l

0.84

947

(3051101) Glucose [Moles/volume] in Cord blood

121

0.41

1.37

3.8

6.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

158

1331

1.19

1.36

2.9

2.7

1.4

1.8

mg/l

7.21

149

1187

(4027681)

183

1.53

1.34

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

337

3768

0.89

1.34

1.8

2.1

9.4

11.7

nmol/l

5.77

277

3207

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

105

851

1.24

1.33

1.1

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.33

0.0

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.04

1.32

2.6

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

674

1.26

1.31

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

674

1.26

1.31

1.2

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

622

1.27

1.29

2.7

3.2

—

(3037121) Protein [Mass/volume] in Urine

168

1965

0.85

1.28

2.4

3.0

0.4

0.3

g/l

0.36

841

(3005988) Vibrio sp identified in Specimen by Organism specific culture

677

1.26

1.27

1.2

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

713

0.76

1.26

1.8

2.0

—

(3034770) Mitochondria Ab [Titer] in Serum

1147

0.81

1.26

1.2

561.7

1027.0

titre

—

(4211845)

291

0.62

1.24

3.6

3.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

117

0.43

1.24

1.6

1.5

11.8

9.7

ug/l

—

117

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

119

0.42

1.24

9.6

10.7

0.7

0.6

mmol/l

—

110

(3037556) Urate [Mass/volume] in Serum or Plasma

190

0.53

1.23

2.3

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

374

0.67

1.22

4.7

11.5

—

(3006462) Nitrate [Presence] in Urine

265

0.60

1.22

2.3

4.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.97

1.22

1.7

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

529

5744

0.91

1.21

2.2

2.4

4.9

6.8

ug/l

2.99

468

4878

(3044242) Glucose [Moles/volume] in Arterial blood

340

1.36

1.19

2.1

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1959

18878

1.05

1.17

3.0

3.2

1298.1

1968.1

ng/l

16.73

1771

16383

(3028707) Methadone [Presence] in Urine by Screen method

165

1.52

1.17

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

126

0.48

1.16

1.0

1.1

1882.5

1598.0

miu/ml

—

126

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2128

22017

0.95

1.16

4.6

4.2

40.9

88.1

ng/l

1.63

1752

17192

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.50

1.15

1.0

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

317

1.36

1.14

1.1

—

(3020491) Glucose [Moles/volume] in Blood

379

0.68

1.13

1.4

2.0

6.4

7.1

mmol/l

0.76

255

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.85

1.13

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

387

1.32

1.13

1.3

1.5

—

(4281824)

449

1.29

1.11

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

127

1497

0.85

1.10

1.7

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.26

1.10

2.0

9.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

683

1.23

1.09

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

101

1212

0.83

1.08

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

693

1.23

1.07

1.2

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1242

11849

1.06

1.07

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.12

1.05

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

123

0.49

1.04

1.3

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.96

1.03

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

358

1.32

1.03

2.2

2.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

679

1.23

1.03

1.2

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

575

0.76

1.01

1.1

—

(40768443) Skin Pathology biopsy report

205

2309

0.88

0.98

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

414

1.28

0.98

1.2

1.3

3.0

2.9

g/l

0.21

294

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

0.98

1.4

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

135

0.52

0.98

1.0

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

266

1.36

0.97

1.0

1.1

51.0

45.9

mg/l

0.25

220

(3002523) Influenza virus A Ag [Presence] in Specimen

318

1.32

0.97

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.97

0.0

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

730

1.21

0.97

6.4

17.8

7.8

7.5

mmol/l

0.26

588

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

568

1.23

0.95

1.2

2.9

3.8

u/ml

0.31

170

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

500

0.76

0.93

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

151

1727

0.87

0.93

4.5

4.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

0.92

1.0

1.1

—

(3017704) Immunofixation for Urine

373

0.72

0.91

1.7

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1.33

0.91

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1.33

0.91

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

287

1.33

0.91

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

244

1.35

0.90

3.7

6.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

194

1726

1.13

0.90

2.2

2.3

0.0

g/l

0.00

174

1574

(3047189) Immunofixation for 24 hour Urine

335

0.72

0.87

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1.31

0.86

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1.31

0.86

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1.31

0.86

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

414

1.26

0.85

1.2

1.3

6.8

7.1

g/l

0.26

290

(3024139) IgG subclass 3 [Mass/volume] in Serum

414

1.26

0.85

1.2

1.3

0.5

0.4

g/l

0.82

295

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

387

4180

0.92

0.85

4.8

2.8

62.1

60.3

ml/min/173m2

0.49

168

1794

(3013707) Erythrocyte sedimentation rate by Westergren method

3543

36064

0.96

0.85

5.3

4.2

21.8

14.4

mm/h

72.25

3371

32759

(3024980) IgG subclass 4 [Mass/volume] in Serum

659

1.20

0.85

1.2

1.5

0.8

0.9

g/l

0.20

499

(3024928) Oxygen saturation in Venous blood

141

1235

1.14

0.84

1.9

2.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

191

2133

0.89

0.83

2.5

3.2

5.0

3.3

ratio

—

160

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

138

0.58

0.83

1.0

1.2

—

30.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

196

1756

1.12

0.82

2.2

2.3

0.0

g/l

0.39

174

1580

(40768797) Stomach Pathology biopsy report

657

6949

0.94

0.82

1.4

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.61

0.81

1.1

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.73

0.79

2.9

3.8

—

(21494434) Karyotype in Bone marrow

553

0.79

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.1

—

266.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

137

1205

1.14

0.78

1.9

2.4

33.1

33.6

umol/l

0.10

109

994

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.77

0.0

3.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

148

1668

0.88

0.77

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

100

0.50

0.77

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

115

1.48

0.76

1.2

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.77

0.76

1.2

1.1

—

3.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

449

0.78

0.75

1.1

1.2

8.2

7.7

mmol/l

0.30

324

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

492

0.79

0.74

1.3

1.6

23.8

26.9

u/ml

—

111

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

219

1.33

0.73

3.4

2.4

—

(4062490)

415

1.23

0.72

1.2

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

140

1242

1.13

0.72

2.7

3.2

106.1

732.8

u/ml

2.01

127

1139

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.75

0.71

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

435

1.22

0.70

1.2

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

238

1.30

0.70

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

227

0.70

0.67

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

156

0.64

0.67

1.5

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

200

2194

0.91

0.67

2.5

3.2

49.8

85.7

mg/l

0.77

152

1786

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

119

1.43

0.66

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

794

7599

1.05

0.66

2.2

2.3

1.8

0.32

712

6601

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

200

2190

0.91

0.65

2.5

3.2

41.7

54.8

mg/l

0.72

155

1784

(3015183) Erythrocyte sedimentation rate

112

1.43

0.63

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

102

0.59

0.62

1.0

1.6

122.5

148.2

ng/l

—

102

(3013293) Extractable nuclear Ab [Presence] in Serum

1.59

0.61

1.8

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

105

0.57

0.61

1.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

244

1.27

0.61

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.60

0.0

1.1

—

0.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

139

0.65

0.60

1.0

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

537

1.17

0.59

1.1

1.3

—

nmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.59

0.0

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

101

1140

0.88

0.59

1.2

1.1

197.0

104.6

titre

—

(3019225) pH of Specimen

609

5814

1.05

0.58

5.9

4.5

—

(3011648) Oxygen content in Venous blood

401

1.20

0.57

1.3

1.8

11.3

10.8

0.28

401

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

586

1.16

0.57

1.1

1.6

1.5

g/l

0.68

521

(3000764) Benzodiazepines [Presence] in Urine

319

1.22

0.56

1.6

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

207

0.72

0.56

2.5

2.2

687.7

5128.2

e6/l

—

144

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

338

1.21

0.55

3.2

5.1

81.2

39.3

u/ml

0.35

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

366

3881

0.94

0.55

1.7

1.8

1.6

2.96

296

3205

(3010838) Calcium [Moles/time] in 24 hour Urine

240

0.75

0.55

1.1

1.7

—

9.5

—

(3045716) Anion gap in Serum or Plasma

284

1.23

0.55

1.8

2.2

8.3

9.4

mmol/l

0.89

228

(3016038) Potassium [Moles/volume] in Urine

385

1.20

0.54

1.1

37.9

35.1

mmol/l

0.39

323

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.58

0.54

1.2

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

2590

0.93

0.54

2.1

2.3

—

(3038515) Glucose [Moles/volume] in Venous blood

127

1405

0.90

0.54

4.5

3.5

7.3

7.8

mmol/l

1.94

127

1375

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

552

1.16

0.54

1.2

3.5

4.7

u/ml

0.81

240

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.49

0.53

1.8

1.5

47.5

44.2

umol/l

0.17

(3044007) Cell count panel - Peritoneal fluid

170

0.71

0.53

3.3

1.9

—

(3027008) Opiates [Presence] in Urine

322

1.21

0.53

1.6

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

112

1245

0.90

0.52

4.4

3.7

38.3

30.7

mg/l

1.02

816

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

2586

0.93

0.52

2.1

2.3

4.1

3.8

g/l

0.88

185

1809

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.62

0.52

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

2592

0.93

0.50

2.1

2.3

8.1

7.4

g/l

5.18

190

1874

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

369

0.81

0.50

1.1

0.6

1.5

u/ml

1.20

139

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

224

1.25

0.50

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

118

1.36

0.50

1.4

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

270

2878

0.94

0.49

4.6

4.1

46.6

47.0

0.10

270

2839

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

234

1.24

0.49

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

934

0.89

0.49

1.2

1.3

6.3

26.2

e6/l

1.86

721

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

933

0.89

0.48

1.2

1.4

768.9

1023.4

e6/l

0.22

763

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

297

3152

0.94

0.48

1.5

1.6

2.0

1.6

g/l

7.42

252

2660

(3022493) Free Hemoglobin [Mass/volume] in Plasma

234

0.77

0.48

1.2

4.1

77.5

65.1

mg/l

—

163

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.35

0.48

1.1

—

(3016750) Collection duration of Urine

344

0.81

0.47

1.8

2.0

494.8

491.4

min

0.06

238

(3048879) Bone marrow aspiration report

200

0.75

0.47

1.1

1.5

—

(3016879) Cocaine [Presence] in Urine

299

1.21

0.47

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

188

0.74

0.46

2.6

2.0

8638.5

19996.8

e6/l

—

107

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

343

0.82

0.46

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

410

4303

0.95

0.46

2.8

3.9

80.4

100.7

ng/l

6.90

363

3628

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.60

0.45

1.6

2.6

0.0

0.3

u/field

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

552

1.14

0.45

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

309

0.81

0.45

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

780

0.88

0.45

3.4

2.0

29.5

25.3

mg/l

0.20

185

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.40

0.45

1.0

1.1

—

29.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

329

1.19

0.44

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

619

1.13

0.44

1.4

149.5

57.9

mu/l

1.06

545

(3029075) Extractable nuclear Ab panel - Serum

112

1.34

0.44

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

117

1282

0.91

0.44

1.8

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

563

1.14

0.44

1.4

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

130

1.31

0.43

1.1

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

0.71

0.43

1.2

2.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

130

0.69

0.43

1.2

1.4

24.3

27.5

g/l

—

102

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

131

0.69

0.43

1.0

1.1

103.7

91.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

317

0.82

0.42

2.1

2.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.43

0.42

2.8

4.6

95.1

64.0

ug/min

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.56

0.42

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.63

0.42

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

623

1.12

0.41

1.1

—

(3028300) Cannabinoids [Presence] in Urine

323

1.18

0.41

1.6

1.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.1

—

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

12634.7

—

(3027874) Urate [Moles/volume] in Urine

0.00

0.40

0.0

1.1

—

1.7

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.1

—

0.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

1.32

0.40

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

100

1097

0.91

0.40

1.2

801.2

587.0

mg/l

0.37

1024

(3034426) Prothrombin time (PT)

132

1.29

0.40

1.1

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

325

0.83

0.39

2.1

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

102

0.69

0.39

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

182

0.77

0.39

2.8

5.7

71.4

70.8

—

142

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.39

0.38

1.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

334

0.84

0.38

1.4

1.8

2.4

2.3

u/field

0.02

232

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.37

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.32

0.37

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

114

0.70

0.37

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

230

2431

0.94

0.36

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

535

0.88

0.36

1.1

1.2

76.1

203.9

miu/ml

—

168

(3000060) B lymphocytes [#/volume] in Blood

1.36

0.36

2.2

1.8

12193.3

1425.6

e6/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.27

0.36

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

189

1.22

0.36

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

122

0.74

0.35

1.3

2.0

184.3

208.2

—

113

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

133

1237

1.08

0.35

1.5

1.4

0.2

g/l

0.10

124

1167

(1617658) Protocol used for examination of sentinel lymph nodes

287

0.84

0.34

1.0

—

(44806071)

1.36

0.34

1.3

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

805

1.09

0.34

4.6

6.6

11.7

12.2

mg/l

0.40

731

(3004119) Hemoglobin [Mass/volume] in Venous blood

359

3741

0.96

0.34

3.4

3.3

122.3

127.6

g/l

4.43

354

3647

(3008401) Mugwort IgE Ab [Units/volume] in Serum

307

0.85

0.33

1.0

1.1

0.5

1.3

u/ml

—

122

(40768793) Breast Pathology biopsy report

807

1.09

0.33

1.2

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

875

1.09

0.32

1.2

9.8

5.4

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.28

0.32

1.7

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

146

1.23

0.32

1.1

—

(3027944) Amphetamines [Presence] in Urine

313

1.15

0.32

1.7

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

163

1534

1.06

0.32

1.2

0.3

1.1

u/ml

2.17

156

(3000093) Morphology [Interpretation] in Blood Narrative

602

0.90

0.32

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

248

1.17

0.31

1.8

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

955

0.92

0.31

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

186

0.81

0.30

2.9

1.8

38.4

53.1

ug/l

1.15

179

(40760888) Immunoglobulin light chains.free panel - Serum

156

1656

0.94

0.30

2.4

3.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

142

0.77

0.30

1.0

1.1

—

8.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.33

0.30

2.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

120

1.25

0.30

9.2

11.2

970.2

814.0

nmol/l

0.37

114

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.31

0.30

1.0

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

231

1.17

0.29

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

231

1.17

0.29

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

174

0.80

0.29

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

228

0.83

0.29

1.9

1.4

24.6

1300.6

u/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

149

1579

0.94

0.28

1.2

—

(4133840)

1.28

0.28

1.5

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

237

0.84

0.27

1.1

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

2394

0.96

0.27

2.1

2.3

3.4

3.1

g/l

6.01

189

1842

(4212803)

1.25

0.27

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

118

0.76

0.27

1.3

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

111

1039

1.07

0.27

1.3

1.2

7.5

6.6

u/ml

0.11

167

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1897

1.05

0.27

2.2

2.3

0.2

0.0

g/l

0.40

177

1713

(3003888) Timothy IgE Ab [Units/volume] in Serum

311

0.87

0.27

1.0

5.4

2.7

u/ml

—

132

(3032057) Clostridioides difficile [Presence] in Stool

159

1.20

0.26

2.1

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.19

0.26

1.1

1.4

—

(4306422)

510

1.10

0.26

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.69

0.26

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.68

0.26

1.8

3.6

36.4

39.7

umol/l

—

(3023520) Reticulocytes [#/volume] in Blood

562

5768

0.97

0.26

2.1

2.5

72.0

67.7

e9/l

1.72

367

4450

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

109

1025

1.06

0.24

1.3

1.2

2.5

3.4

u/ml

0.84

104

(3004775) Volume in Urine collected for unspecified duration

507

0.91

0.24

2.0

2.2

653.8

649.6

0.02

310

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

657

1.08

0.24

1.1

1.4

152.4

125.7

u/ml

0.28

135

(44806420)

212

0.85

0.24

2.3

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

124

1.21

0.24

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.32

0.23

1.2

1.1

94.4

77.5

ug/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

332

1.12

0.23

2.6

2.1

82.0

171.7

ug/min

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

179

0.84

0.23

2.9

2.4

—

31.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

304

1.12

0.22

1.5

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.25

0.22

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

829

8138

1.02

0.22

2.2

2.7

18.9

21.9

6.58

743

6820

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.74

0.22

1.0

—

(3049717) Cytology report of Urine Cyto stain

284

2937

0.97

0.22

3.0

2.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

116

1098

1.06

0.22

1.3

1.2

36.5

40.1

u/ml

0.06

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1990

1.04

0.21

2.1

2.2

36.7

37.1

g/l

0.51

181

1673

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

875

1.06

0.21

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

440

4288

1.03

0.21

3.8

4.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

107

1.22

0.21

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.9

—

358.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

1.9

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

1.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.3

—

3.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

5.6

—

45.8

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

105

0.76

0.21

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.19

0.21

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

38.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

134

0.82

0.20

2.2

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

145

1.17

0.20

33.2

30.4

7.6

7.2

ug/l

0.25

126

(3038026) Centromere Ab [Units/volume] in Serum

383

1.10

0.20

1.2

1.4

61.9

u/ml

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.20

0.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

113

0.80

0.20

1.9

3.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

115

0.78

0.20

1.2

1.9

1.2

ug/l

—

106

(3043410) Blood group antigens tested for on Red Blood Cells

174

1.15

0.19

1.6

1.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

471

1.08

0.19

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

212

1.13

0.19

1.8

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

129

1350

0.95

0.19

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

684

0.94

0.18

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

270

2781

0.97

0.18

1.8

1.9

1.4

g/l

1.14

247

2473

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.21

0.18

1.1

1.0

—

(3001729) Color of Synovial fluid

1.19

0.18

1.7

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.19

0.18

1.4

2.3

—

41.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

216

0.88

0.17

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.15

0.17

1.7

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.17

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

176

1.14

0.17

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

299

0.90

0.17

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

129

1345

0.96

0.17

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

186

1.13

0.17

1.1

1.0

1.2

u/l

1.24

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

1334

0.96

0.16

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

234

1.11

0.16

1.4

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

956

0.95

0.16

1.2

3.8

3.9

mmol/l

1.10

885

(3037756) Immunofixation for Serum or Plasma

140

1455

0.96

0.16

1.5

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

158

1.14

0.16

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

867

1.05

0.16

3.0

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

442

0.93

0.15

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

668

0.94

0.15

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

120

1152

1.04

0.15

1.3

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

159

1.13

0.15

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

517

1.06

0.15

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.10

0.15

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

150

1.13

0.14

1.2

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

133

1283

1.04

0.14

1.6

1.5

1.1

1.2

g/l

0.96

124

1209

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

347

0.92

0.14

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

859

0.95

0.14

1.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

212

2177

0.97

0.13

2.2

2.4

1.3

1.1

g/l

0.20

178

1830

(3006922) Hepatitis E virus Ab [Presence] in Serum

247

1.09

0.13

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

152

1473

1.03

0.13

3.0

0.8

nmol/l

0.06

118

1104

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

159

0.88

0.13

1.0

1.1

—

(3024932) HLA-DR beta [Type]

106

0.85

0.13

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

106

0.85

0.13

1.0

1.1

—

(3024471) HLA-A [Type]

108

0.83

0.13

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

267

1.09

0.13

1.1

1.5

13.3

6.3

u/l

0.64

225

(3035285) Chloride [Moles/volume] in Venous blood

883

1.04

0.13

3.0

2.5

104.4

105.8

mmol/l

1.72

872

(3041354) Potassium [Moles/volume] in Venous blood

883

1.04

0.13

3.0

2.5

4.2

4.1

mmol/l

0.40

872

(3044941) Cell count panel - Synovial fluid

846

0.96

0.13

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

919

9290

0.99

0.12

2.1

2.6

10.1

12.1

umol/l

14.46

868

8491

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

221

0.90

0.12

2.3

2.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

375

1.07

0.12

1.2

24.5

37.0

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

620

0.95

0.12

1.2

1.4

—

(3021788) Differential panel - Synovial fluid

984

0.96

0.11

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

173

1.10

0.10

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

290

0.93

0.10

1.2

7.4

12.2

mmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

870

1.03

0.10

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

135

0.89

0.09

2.6

2.7

7.0

18.7

mu/l

6.01

126

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

166

0.90

0.09

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

232

1.08

0.09

1.4

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

861

1.03

0.09

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

664

1.04

0.09

1.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

0.89

0.09

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

858

8651

0.99

0.09

2.1

2.6

2.2

g/l

2.01

809

7908

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

349

0.95

0.08

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

578

1.04

0.08

1.2

1.3

304.4

258.5

pmol/l

0.65

435

(42529582) MDA5 Ab [Presence] in Serum by Line blot

127

1.10

0.07

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

127

1.10

0.07

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

127

1.10

0.07

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

127

1.10

0.07

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

786

1.03

0.07

1.1

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

555

5498

1.01

0.07

1.3

582.7

504.0

titre

0.47

139

1188

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.86

0.07

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.12

0.07

3.4

4.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.81

0.07

1.5

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

372

1.05

0.07

1.2

1.1

62.2

78.0

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.80

0.07

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

422

1.04

0.07

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.82

0.07

5.3

14.3

5.7

5.1

mmol/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

907

1.03

0.07

1.2

—

11.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

611

6063

1.01

0.06

4.8

3.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

102

0.88

0.06

3.7

2.5

151.6

136.1

nmol/l

—

(3033799) Differential panel - Peritoneal fluid

187

1.07

0.06

2.4

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

618

0.97

0.06

1.1

1.2

295.2

296.7

u/ml

0.01

363

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

304

0.95

0.05

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

178

1.07

0.05

2.9

2.7

30.4

29.4

umol/l

0.15

129

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

385

1.04

0.05

1.3

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

139

1.08

0.05

1.1

—

(44813793)

222

0.95

0.05

1.1

—

(3014271) Vancomycin [Susceptibility]

418

1.03

0.03

2.8

3.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

0.93

0.03

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

348

3503

0.99

0.03

2.1

2.7

10.2

10.6

g/l

1.29

319

3161

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

310

0.97

0.03

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

310

0.97

0.03

1.6

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

450

0.98

0.02

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

239

2404

0.99

0.02

2.1

2.3

10.5

10.3

g/l

0.32

200

2000

(3017732) Neutrophils [#/volume] in Blood

325

3239

1.00

0.01

4.1

3.3

5.1

4.2

e9/l

4.42

248

2277

(3012565) Volume of 24 hour Urine

263

1.03

0.01

2.0

2.4

1797.9

1818.3

0.03

218

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

306

0.98

0.00

1.3

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

447

4477

1.00

0.00

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

572

5713

1.00

0.00

2.9

3.1

191.4

262.4

ng/l

4.40

532

5249

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

636

0.99

0.00

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

744

1.01

0.00

1.3

1.2

62.6

45.6

u/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

113

0.97

0.00

1.5

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

0.96

0.00

1.0

1.3

97.2

79.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

204

0.98

0.00

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

325

1.02

0.00

1.3

1.1

promille

0.38

248

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

108

1.02

0.00

1.4

1.5

—

(40762814) Titanium [Mass/volume] in Blood

112

0.98

0.00

2.2

2.1

7.4

3.2

ug/l

—

(40768446) Kidney Pathology biopsy report

162

0.99

0.00

1.2

1.5

—

(4268621)

368

1.01

0.00

2.1

2.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

101

0.99

0.00

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

151

0.99

0.00

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

299

1.00

0.00

1.0

1.1

—

(3024263) Appearance of Synovial fluid

311

1.00

0.00

1.5

1.6

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.4

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

190

1.00

0.00

1.0

1.1

6.4

13.0

iu/ml

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3230.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.91

0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

6.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.98

0.00

1.0

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.95

0.00

1.2

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1468.8

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.92

0.00

1.2

—

95.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.98

0.00

14.8

11.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.00

0.00

1.0

1.2

100.0

81.8

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LUNG_NONSMALL – Non-small cell lung cancer

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-small cell lung cancer

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-small cell lung cancer (C3_LUNG_NONSMALL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints